Cuninghame S, Jerath A, Burry L, Orser B, Slessarev M et al. The effect of inhaled anesthestics on cognitive and psychiatric outcomes in critically ill adults: A systematic review and meta-analysis. BJA. May 2023; In Press

Ribeiro T, Mahar A, Jerath A, Bondzi-Simpson A, Barabash V, Barr AA, Wright F, Kosyachkova E, Deleemans J, Coburn N, Hallet J. Novel patient-centred outcome in cancer care, days-at-home: A scoping review protocol. BMJ Open. Mar 2023; 13:e071201. DOI: 10.1136/bmjopen-2022-071201. 

Malhotra AK, Chang A, Lawton JP, Costa Alves A Jr, Jerath A, Tillmann BW, Foster H, Mashari A, Da Costa L, Kumar A. Intra-operative air embolism diagnosis and treatment using hyperbaric oxygen therapy after craniotomy. Journal of Neurosurgery. Mar 2023; 5(12):CASE2342. DOI: 10.3171/CASE2342. 

Azizi PM, Wijeysundera DN, Wijeysundera HC, Austin PC, Jerath A, Kayssi A, Ko DT. Association between hospital post-operative troponin use and patient outcomes after vascular surgery. Anesthesia Analgesia. Mar 2023; online ahead of print. DOI: 10.1213/ANE.0000000000006411. 

 Jerath A, Slessarev M. The impact of the coronavirus pandemic on sedation in critical care. Curr Opin Crit Care. Feb 2023; 29(1):14-18. DOI: 10.1097/MCC.0000000000001011. 

Hallet J, Sutradhar R, Jerath A, d’Empaire P, Carrier F, Turgeon A, McIsaac DI, Idestrup C, Lorello G, Flexman A, Kidane B, Kaliwal Y, Chan WC, Barabash V, Coburn N, Eskander A. Association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery. JAMA Surgery. Feb 2023; online ahead of print. DOI: 10.1001/jamasurg.2022.8228. 

Hallet J, Sutradhar R, Eskander A, Carrier FM, McIsaac D, Turgeon AF, Perez D’Empaire P, Idestrup C, Flexman A, Lorello G, Darling G, Kidane B, Wing C Chan, Barabash V, Coburn N, Jerath A. Variation in anesthesiology provider-volume for complex gastrointestinal cancer surgery: a population-based study. Annals of Surgery. Jan 2023; online ahead of print. DOI:10.1097/SLA.0000000000005811 

Roberts DJ, Mor R, Rosen MN, Talarico R, Lalu MM, Jerath A, Wijeysundera DN, McIsaac DI. Hospital-, anesthesiologist-, surgeon-, and patient-level variation in neuroaxial anesthesia use for lower limb revascularization: A population-based cross-sectional study. Anesth Analg. Dec 2022; 135(6):1282-1292. DOI 10.1213/ANE.0000000000006232. 

Lim K, Satkunasivam R, Nipper C, Xu J, Hsu E, Slawin JR, Roy T, Allenson KC, Kim MP, Barber SM, Ellis T, Akinsola O, Klaassen Z, Esnaola N, Ravi B, Jerath A, Wallis CJD. Association between isolated abnormal coagulation profile on transfusion following major surgery: A NSQIP analysis of individuals without bleeding disorders. Transfusion. Nov 2022; 62(11)2223-2234. DOI: 10.1111/trf.17146. 

Nipper CA, Lim K, Riveros C, Hsu E, Ranganathan S, Xu J, Brooks M, Esnaola, Klaassen Z, Jerath A, Arrington A, Wallis CJD, Satkunasivam R. The Association between Serum Albumin and Post-Operative Outcomes among Patients Undergoing Common Surgical Procedures: An Analysis of a Multi-Specialty Surgical Cohort from the National Surgical Quality Improvement Program (NSQIP). J Clin Med. Nov 2022;11(21)6543. DOI: 10.3390/jcm11216543. 

Hallet J, Jerath A, Perez d’Empaire P, Eskander A, Carrier FM, McIsaac DI, Turgeon AF, Idestrup C, Flexman AM, Lorello G, Darling G, Kidane B, Kaliwal Y, Barabash V, Coburn N, Sutradhar R. The Association between Hospital High-volume Anesthesiology Care and Patient Outcomes for Complex Gastrointestinal Cancer Surgery: A Population-based Study. Ann Surg. Oct 2022; online ahead of print. DOI: 10.1097/SLA.0000000000005738. 

Daza JF, Cuthbertson BH, Myles PS, Shulman MZ, Wijeysundera DN. METS study investigators. Measurement properties of the WHO Disability Assessment Schedule 2.0 for evaluating functional status after inpatient surgery. Br J Surgery. Sep 2022;109(10):968-76. DOI: 10.1093/bjs/znac263 

Nguyen DD, Murad L, Nguyen AXL, Bouhadana D, Deyirmendjian C, Zorn KC, Elterman, D, Chughtai B, Sayyid RK, Labban M, Tring QD, Wallis CJD, Bhojani N. Industry payments to American editorial board members of major urology journals. Eur Urol 2023 (e-published 29 April). doi:10.1016/j.eururo.2023.04.017. Role: co-author.

Hall ME, Padgett WJ, Klaassen Z, Magee DE, Luckenbaugh AN, Laviana AA, Satkunasivam R, Schaffer K, Wallis CJD. Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: a meta-analysis of RCTs. Clin Genitourin Cancer 2023 (e-published 22 April). DOI:10.1016/j.clgc.2023.04.007. Role: senior author.

Roy S, Wallis CJD, Morgan S, Kishan A, Malone J, Sun Y, Spratt DE, Saad F, Malone S. Implications of Metastatic Stage at Presentation in Docetaxel naïve Metastatic Castrate Resistant Prostate Cancer. The Prostate 2023 (e-published 18 April). DOI:10.1002/pros.24512. Role: co-author.

Matta R, Wallis CJD, Etches J, Saskin R, Lorenzo A, Vigil HR, Kodama RT, Radomski S, Nam RK, Carr L, Herschorn S. Healthcare utilization during transition to adult care in patients with spina bifida: A population-based longitudinal study in Ontario, Canada. Can Urol Assoc J 2023 (e-published 20 March). DOI: https://doi.org/10.5489/cuaj.8247. Role: co-author.

Roy S, Sun Y, Morgan SC, Wallis CJD, King K, Zhou YM, D’Souza LA, Azem O, Cueto-Marquez AE, Camden NB, Spratt DE, Kishan A, Saad F, Malone S. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023 (e-published 7 March). https://doi.org/10.1016/j.eururo.2023.02.017. Role: co-author.

Nguyen DD, Wallis CJD, Fleshner NF, Klaassen Z, Trinh QD, Sayyid R. Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap. Eur Urol Focus 2023 e-published 25 February). https://doi.org/10.1016/j.euf.2023.02.006. Role: co-author.

Lim K, Riveros C, Ranganathan S, Xu J, Patel A, Slawin J, Ordonez A, Aghazadeh M, Morgan M, Miles BJ, Esnaola N, Klaassen Z, Allenson K, Brooks M, Wallis CJD, Satkunasivam R. Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database. Urol Oncol 2023 (e-published 19 February). https://doi.org/10.1016/j.urolonc.2023.01.003. Role: co-author and primary methodologist.

Aminoltejari K, Hird AE, Klaassen Z, Satkunasivam R, Kulkarni GS, Luckenbaugh AN, Laviana AA, Wallis CJD, Clark R. Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses. Ann Surg Oncol 2023 (e-published 11 February). doi: 10.1245/s10434-022-12692-w. Role: co-author.

Nguyen DD, Labban M, Briggs L, Wallis CJD, Cole AP, Lipsitz LR, Iyer HS, Rebbeck TR, Weissman JS, Choueiri TK, Trinh QD. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations. Urol Oncol 2023 (e-published 8 February). DOI: 10.1016/j.urolonc.2023.01.011. Role: co-author.

Richard PO, Podasca TB, Desjardins A, Couture F, Bhojani N, Lee J, Matsumoto ED, Nguyen DD, Wallis CJD. UroBOT: A National Survey of Canadian Urology Residents and Fellows on Robot-Assisted Surgery. Can Urol Assoc J 2022 (e-published 2 February). DOI: 10.5489/cuaj.8186. Role: senior author.

Riveros C, Huang EY, Ranganathan S, Klaassen Z, Rini B, Wallis CJD, Satkunasivam R. Adjuvant Immunotherapy in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. BJU International 2023; 131(5):553-561. DOI: 10.1111/bju.15981. Role: co-author and primary methodologist.

Riveros C, Ranganathan S, Xu S, Chang C, Kaushik D, Morgan M, Miles CJ, Muhammad T, Anis M, Geng MJ, Zhang J, Efstatiou E, Klaassen Z, Brooks M, Rini B, Wallis CJD, Satkunasivam R. Comparative Real-World Survival Outcomes of Metastatic Papillary and Clear Cell Renal Cell Carcinoma Treated with Immunotherapy, Targeted Therapy, and Combination Therapy. Urol Oncol 2023 (e-published 5 January). https://doi.org/10.1016/j.urolonc.2022.11.022. Role: co-author.

Tallman J, Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Goodman M, Hamilton AS, Wu XC, Paddock L, Stroup AM, Cooperberg M, Hashibe M, O’Neil BB, Kaplan S, Greenfield S, Hoffman KE, Barocas DA. Prostate volume, baseline urinary function, and their association with treatment choice and post-treatment urinary function in men treated for localized prostate cancer. Prostate Cancer Prostatic Dis 2022 (e-published 8 December). DOI: 10.1038/s41391-022-00627-1. Role: co-author.

Sayyid R, Benton J, Reed W, Ma M, Woodruff P, Terris M, Wallis CJD, Klaassen Z. Prostate cancer mortality rates in low and favourable intermediate-risk active surveillance patients: a population-based competing risks analysis. World J Urol 2022 (e-published 6 December). https://doi.org/10.1007/s00345-022-04228-4. Role: co-senior author.

Saad F, Bhindi B, Noonan K, Ong M, Castellano K, Kourkounaskis A, Wallis CJD. Assessment of the epidemiological trends for prostate cancer using administrative data in Ontario. Can Urol Assoc J 2022 (e-published 6 December). http://dx.doi.org/10.5489/cuaj.8099. Role: senior author.

Nam R, Patel C, Milot L, Hird AE, Wallis CJD, McInnis P, Singh M, Emmenegger U, Sherman C, Haider MA. Prostate MRI versus PSA Screening for Prostate Cancer Detection (The MVP Study): A Randomised Clinical Trial. BMJ Open 2022;12:e059482. doi: 10.1136/bmjopen-2021-059482. Role: co-author.

Nipper CA, Lim K, Riveros C, Hsu E, Rnganathan S, Xu J, Brooks M, Esnaola N, Klaassen Z, Jerath A, Arrington A, Wallis CJD, Satkunasivam R. The Association Between Serum Albumin and Post-Operative Outcomes Among Patients Undergoing Common Surgical Procedures: An Analysis of a Multi-Specialty Surgical Cohort from the National Surgical Quality Improvement Program (NSQIP). Journal of Clinical Medicine 2022; 11(21):6453. https://doi.org/10.3390/jcm11216543. Role: co-author.

Samora N, Wallis CJD, Tallman JE, Huang JC, Zhao Z, Conwill R, Cooperberg M, Goodman M, Greenfield S, Hamilton A, Hashibe M, Hoffman K, Kaplan S, O’Neil B, Paddock L, Penson D, Stroup A, Wu XC, Koyama T, Barocas D. Association between body mass index and localized prostate cancer treatment modality and patient-reported outcomes. BJUI Compass 2023; 4(2):223-233. https://doi.org/10.1002/bco2.197. Role: co-author and primary methodologist.

NIHR Global Health Unit of Global Surgery, COVIDSurg Collaborative. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries. The Lancet; 400(10363):p1607-1617. https://doi.org/10.1016/S0140-6736(22)01846-3. Role: co-author.

Britton CJ, Andrews JR, Wallis CJD, Sharma V, Leibovich BC, Thompson RH, Boorjian SA, Bhindi B, Costello BA. Deferred Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Urol Oncol 2022 (e-published 28 October). doi:10.1016/j.urolonc.2022.09.021. Role: co-author and primary methodologist.

Riveros C, Ranganathan S, Nipper C, Lim K, Brooks M, Dursun F, Miles B, Goh A, Desai M, Klaassen Z, Kulkarni G, Wallis CJD, Satkunasivam R. Open vs Robot-Assisted Radical Cystectomy with Extracorporeal or Intracorporeal Urinary Diversion for Bladder Cancer: A Pairwise Meta-Analysis of Outcomes and a Network Meta-analysis of Complications by Urinary Diversion Approach. Can Urol Assoc J 2022 (e-published 25 October). DOI: 10.5489/cuaj.8096. Role: co-author and primary methodologist.

Joyce DD, Wallis CJD, Huang JC, Hoffman K, Zhao Z, Koyama T, Conwill R, Goodman M, Hamilton A, Wu XC, Paddock L, Stroup A, Cooperberg M, Hashibe M, O’Neil B, Kaplan S, Greenfield S, Penson D, Barocas D. The Association Between Financial Toxicity and Treatment Regret in Men with Localized Prostate Cancer. JNCI Cancer Spectrum 2022 (e-published 18 October). DOI: 10.1093/jncics/pkac071. Role: co-author.

Lim K, Satkunasivam R, Nipper C, Xu J, Hsu E, Slawin JR, Roy T, Allenson KC, Kim MP, Barber SM, Ellis T, Akinsola O, Klaassen Z, Esnaola N, Ravi B, Jerath A, Wallis CJD. Association between isolated abnormal coagulation profile on transfusion following major surgery: A NSQIP analysis of individuals without bleeding disorders. Transfusion 2022;62(11):2223-2234. DOI:10.1111/trf.17146. Role: senior author.

Roy S, Sun Y, Wallis CJD, Morgan S, Grimes S, Malone J, Kishan A, Mukerjee D, Spratt D, Saad F, Malone S. Association of Dynamic Change in Patient-reported Pain with Survival in Metastatic Castrate Sensitive Prostate Cancer – Exploratory Analysis of LATITUDE Study. Prostate Cancer Prostatic Dis 2022 (e-published 13 September). Doi: 10.1038/s41391-022-00529-2. Role: co-author.

Klaassen Z, Howard L, Wallis CJD, De Hoedt A, Aronson W, Polascik L, Amling C, Kane C, Cooperberg M, Terris, Wu Y, Freedland S, Janes J. Is Time to Castration Resistant Prostate Cancer a Potential Intermediate End-Point for Time to Metastasis Among Men Initiating Androgen Deprivation Therapy for Non-Metastatic Prostate Cancer with Rapid PSA Doubling Time (<9 Months)? Prostate Cancer Prostatic Dis 2022 (e-published 1 September). doi:10.1038/s41391-022-00585-8. Role: co-author.

De B, Pasalic D, Barocas DA, Wallis CJD, Huang JC, Zhao Z, Koyama T, Tang C, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman K. Patient-Reported Outcomes after External Beam Radiotherapy with Low Dose-Rate Brachytherapy Boost versus Radical Prostatectomy for Localized Prostate Cancer: Five-Year Results from a Prospective Comparative Effectiveness Study. J Urol 2022 (e-published 25 August). doi:10.1097/JU.0000000000002902. Role: co-author.

Sayyid RK, Hiffa A, Woodruff P, Oberle MD, Lambert JH, Terris MK, Wallis CJD, Klaassen Z. Suspension of Oncology Randomized Clinical Trials During the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions. Cancer Investigation. 2022; 40(9): 743-749. https://doi.org/10.1080/07357907.2022.2104305. Role: co-author.

Roy S*, Sayyid R*, Saad F, Sun Y, Lajkosz K, Ong M, Klaassen Z, Malone S, Spratt DE, Wallis CJD**, Morgan SC**. Addition of Docetaxel to Androgen Receptor Axis-Targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone Sensitive Prostate Cancer: A Network Meta-Analysis. Eur Urol Oncol 2022 (e-published 7 July). *=co-first author. **=co-senior author. doi: https://doi.org/10.1016/j.euo.2022.06.003. Role: co-senior author.

Roy S, Sun Y, Wallis CJD, Morgan S, Grimes S, Malone J, Kishan A, Mukerjee D, Spratt D, Saad F, Malone S. Development and Validation of a Multivariable Prognostic Model in de novo Metastatic Castrate Sensitive Prostate Cancer. Prostate Cancer Prostatic Dis 2022 (e-published 5 July). doi: https://doi.org/10.1038/s41391-022-00560-3. Role: co-author.

Satkunasivam R, Lim K, The BS, Guzman J, Zhang J, Farach A, Chen SH, Wallis CJD, Efstathiou E, Esnaola NF, Sonpavde G. A Phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin ineligible muscle invasive bladder cancer: the RAD VACCINE MIBC Trial. Future Oncology 2022 (e-published 15 June). doi: https://doi.org/10.2217/fon-2022-0380. Role: co-author.

Launer BM, Sayyid RK, Klaassen Z, Whelan E, Magee DE, Luckenbaugh AN, Wallis CJD. On the Shoulders of Giants: Correlation of Rates of Female First Authorship with Senior Authorship Gender. Brit J Surg 2022 (e-published 6 June). DOI: 10.1093/bjs/znac163. Role: senior author.

Wallis CJD, Jerath A, Kaneshwaran K, Hallet J, Coburn N, Wright FC, Gotlib-Coon L, Bischoff D, Covelli A, Klaassen Z, Zlotta AR, Kulkarni GS, Luckenbaugh AN, Armstrong K, Lim K, Bass B, Detsky AS, Satkunasivam R. Association between surgeon and anesthesiologist sex discordance and postoperative outcomes: a population-based cohort study. Ann Surg 2022; 276(1):81-7. DOI: 10.1097/SLA.0000000000005495. Role: primary author.

Malone S, Wallis CJD, Lee-Ying R, Basappa NS, Cagiannos I, Hamilton RJ, Fernandes R, Ferrario C, Gotto GT, Morgan SC, Morash C, Niazi T, Noonan KL, Rendon R, Hotte SJ, Saad F, Zardan A, Osborne B, Chan KFY, Shayegan B. Patterns of Care for Patients with Non-metastatic Castration-Resistant Prostate Cancer: Population-based Study in Canada. BJUI Compass 2022; 3(5):383-391. doi: 10.1002/bco2.158. Role: co-author and primary methodologist.

Manogue CE, Chen W, Mazza A, Dang A, Lewis B, Wallis CJD, Layton J, Barata P, Sartor O, Harris KM. Embracing the Practical Aspects of Theranostics with PSMA-Targeted Lutetium-177. Pract Radiat Oncol 2022 (e-published 14 May). https://doi.org/10.1016/j.prro.2022.01.008. Role: co-author.

Dursun F, Lim K, Svatek RS, Xu J, El-Zaatari Z, Wenker E, Klaassen Z, Muhammed T, Efsathiou E, Sonpavade G, Wallis CJD, Satkunasivam R. Clinical Outcomes and Patterns of Population Based Management of Urachal Carcinoma: An analysis of the National Cancer Database. Cancer Med 2022 (e-published 4 May). DOI: 10.1002/cam4.4786. Role: co-author.

Lee SG, Fralick J, Wallis CJD, Boctor M, Sholzberg M, Fralick M. Systematic review of Hematuria and Acute Renal failure with tranexamic acid. Eur J Haematol 2022;108(6):510-517. DOI: 10.1111/ejh.13762. Role: co-author. 

Celtik K, Wallis CJD, Lo M, Lim K, Lipscomb J, Fleming S, Wu XC, Anderson RT, Thompson TD, Farach A, Hamilton AS, Miles BJ, Satkunasivam R. Mortality Following Radical Prostatectomy or Intensity Modulated Radiation Therapy for Localized Prostate Cancer – An Analysis of the CDC Breast and Prostate Cancer Data Quality and Patterns of Care Study (CDC PoC-BP). Can Urol Assoc J 2021 (e-published 28 February). http://dx.doi.org/10.5489/cuaj.7580. Role: co-author and primary methodologist.

Tallman JE, Wallis CJD, Huang JC, Zhao Z, Penson D, Koyama T, Conwill R, Goodman M, Hamilton A, Wu XC, Paddock L, Stroup A, Cooperberg M, Hashibe M, O’Neil B, Kaplan S, Greenfield S, Barocas D, Hoffman K. Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer. Prostate Cancer Prostatic Dis 2022 (e-published 25 February). https://doi.org/10.1038/s41391-022-00518-5. Role: co-author and primary methodologist.

Shayegan B, Wallis CJD, Malone S, Cagiannos I, Hamilton RJ, Ferrario C, Gotta GT, Basappa NS, Morgan SC, Fernandes R, Morash C, Niazi T, Noonan KL, Rendon R, Osborne B, Park-Wyllie L, Chang KFY, Hotte SJ, Saad F. Real-World Use of Systemic Therapies in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) in Canada. Urol Oncol 2022 (e-published 23 February). doi: 10.1016/j.urolonc.2022.01.009. Role: co-author and primary methodologist.

Shayegan B, Wallis CJD, Hamilton RJ, Morgan SC, Cagiannos I, Basappa NS, Ferrario C, Gotta GT, Fernandes R, Roy S, Noonan KL, Niazi T, Hotte SJ, Saad F, Hew H, Park-Wyllie L, Chang KFY Malone S. Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada. Prostate Cancer Prostatic Dis 2022 (e-published 23 February). doi:10.1038/s41391-022-00514-9. Role: co-author, primary methodologist, and corresponding author.

Klaassen Z, Assel MJ, Vickers AJ, Vertosick E, Novara G, Pierce C, Wallis CJD, Larcher A, Cooperberg MR, Catto JWF, Kutikov, A. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology. Eur Urol 2022 (e-published 9 February).https://doi.org/10.1016/j.eururo.2022.01.041. Role: co-author.

Celtik K, Lim K, Dursun F, Xu J, Klaassen Z, Zhang J, Efstathiou E, Sonpavade G, Wallis CJD, Satkunasivam R. Association between perioperative chemotherapy and survival in men undergoing radical resection for primary urethral urothelial carcinoma: An Analysis of the National Cancer Database. Clin Genitourin Cancer 2022 (e-published 27 January). doi:10.1016/j.clgc.2022.01.011. Role: co-author and primary methodologist.

Luckenbaugh AN, Wallis CJD, Huang LC, Wittman D, Klaassen Z, Zhao Z, Koyama T, Laviana AA, Conwill R, Goodman M, Hamilton A, Qu XC, Paddock L, Stroup A, Cooperberg M, Hashibe M, O’Neil B, Kaplan S, Greenfield S, Hoffman K, Penson D, Barocas DA. Association between treatment for localized prostate cancer and mental health outcomes. J Urol 2022; 207:1029-1037. doi:10.1097/JU.0000000000002370. Role: co-author and primary methodologist.

Tiwari R, Lajkosz K, Fleshner N, Wallis CJD. Have we mis-PRONOUNCEd the cardiovascular risk of GnRH agonists? A critical appraisal of the PRONOUNCE trial. Prostate Cancer Prostatic Dis 2022 (4 January). https://doi.org/10.1038/s41391-021-00483-5. Role: senior author.

Wallis CJD, Jerath A, Coburn N, Klaassen Z, Luckenbaugh AN, Magee DE, Hird AE, Armstrong K, Ravi B, Esnaola NF, Guzman JCA, Bass B, Detsky AS, Satkunasivam R. Association between surgeon-patient sex concordance and post-operative outcomes: a population-based cohort study. JAMA Surgery 2022; 157(2):146-156. doi:10.1001/jamasurg.2021.6339. Role: primary author.

Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Kaplan S, Greenfield S, Luckenbaugh AN, Klaassen Z, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Hoffman KE, Barocas DA. Treatment-related regret among men with localized prostate cancer: understanding the contribution of treatment modality, functional outcomes, and baseline characteristics. JAMA Oncology 2022; 8(10):50-59. doi:10.1001/jamaoncol.2021.5160. Role: primary author.

Lee MC, Erickson TR, Stock S, Howard LE, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Freedland SJ, Wallis CJD. Association between delay to radical prostatectomy and clinically meaningful outcomes among patients with intermediate- and high-risk localized prostate cancer. J Urol 2022; 207(3):592-600. doi:10.1097/JU.0000000000002304. Role: senior author.

Satkunasivam R, Guzman JCA, Klaassen Z, Hall ME, Luckenbaugh AN, Lim K, Laviana AA, DeRose AP, Beckermann KE, Rini B, Wallis CJD. Association between prior nephrectomy and efficacy of immune checkpoint inhibitor therapy in metastatic renal cell carcinoma – a systematic review and meta-analysis. Urol Oncol 2022; 40(2):64e17-64.e24. doi: https://doi.org/10.1016/j.urolonc.2021.09.009. Role: senior author and primary methodologist.

Sui W, Hall ME, Barocas DA, Chang SS, Luckenbaugh AN, Moses KA, Penson DF, Wallis CJD, Laviana AA. Association between surgical volume and survival among patients with variant histologies of bladder cancer. Urology 2022; 159:p100-106. doi: https://doi.org/10.1016/j.urology.2021.09.009. Role: primary methodologist.

Dursun F, Mackay A, Guzman JCA, Wenker E, Klaassen Z, O’Malley P, Bhindi B, Obando Perez C, Xu J, Roh T, Sonpavade G, Wallis CJD, Satkunasivam R. Utilization and Outcomes of Metastasectomy for Patients with Metastatic Urothelial Cancer: An Analysis of the National Cancer Database. Urol Oncol 2022; 40(2):61.e21-61.e28. https://doi.org/10.1016/j.urolonc.2021.07.015. Role: primary methodologist.

COVIDSurg Collaborative and GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia 2022; 77(1):28-39. doi: https://doi.org/10.1111/anae.15563. Role: co-author/contributor.

Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Tallman JE, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: an assessment of the CEASAR cohort. Urol Oncol 2022; 40(2): 56.e1-56.e8. https://doi.org/10.1016/j.urolonc.2021.04.035. Role: primary author.

Sayyid RK, Lokeshwar SD, Tella D, Jones CE, Oberle MD, Woodruff P, Klaassen Z, Wallis CJD. Transparency of Racial Participation Reporting in Randomized Controlled Trials of Minimally Invasive Surgical Techniques. Surg Endosc 2022; 36:2600-2606. doi:10.1007/s00464-021-08550-7. Role: senior author.

Goldberg H, Mohsin FK, Chandrasekar T, Wallis CJD, Klaassen Z, Ahmad AE, Saskin R, Kenk M, Saarela O, Kulkarni GS, Alibhai SMH, Fleshner N. The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy. Can Urol Assoc J 2022; 16(5):e248-e255. doi: 10.5489/cuaj.7464. Role: co-author.

Wallis CJD, Malone S, Cagiannos I, Morgan SC, Hamilton RJ, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Niazi T, Noonan KL, Saad F, Hotte SJ, Hew H, Chan KFY, Park Wyllie L, Shayegan B. Real-World Utilization of Androgen Deprivation Therapy-Intensification Among Older Canadian Men With de novo Metastatic Prostate Cancer. JNCI Cancer Spectr 2021 (e-published 1 October). doi: https://doi.org/10.1093/jncics/pkab082. Role: primary author.

Poon SJ, Wallis CJD, Lai P, Podczerwinski L, Buntin MD. Medicare Two-Midnight Rule Accelerated Shift to Observation Stays. Health Aff 2021; 40(11): 1688-1696. doi: 10.1377/hlthaff.2021.00094. Role: co-author.

Wallis CJD*, Joyce DD*, Klaassen Z, Luckenbaugh AN, Laviana AA, Penson D, Dusetzina SB, Barcoas DA. Out-of-pocket costs for commercially insured patients with localized prostate cancer. Urol Oncol 2021; 39(12):797-805. doi: https://doi.org/10.1016/j.urolonc.2021.08.026. * = authors contributed equally. Role: co-primary author and primary methodologist.

Sayyid RK, Klotz L, Benton JZ, Ma M, Woodruff P, Satkunasivam R, Terris MK, Wallis CJD*, Klaassen Z*. Active Surveillance in Favorable Intermediate Risk Prostate Cancer Patients: Predictors of Deferred Intervention and Choice of Treatment. Can Urol Assoc J 2021; 16(1):e7-14. doi: https://doi.org/10.5489/cuaj.7272. * = authors contributed equally. Role: co-senior author.

Anassie J, Dursun F, Wallis CJD, Klaassen Z, Obando-Perez C, Xu S, Boone T, Khavari R, Satkunasivam R. Dissecting the Role of Radical Cystectomy and Urinary Diversion in Post-Operative Complications: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database. Int Braz J Urol. 2021; 47(5):1006-1019. doi: 10.1590/S1677-5538.IBJU.2020.1098. Role: co-author.

Dymanus K, Butaney M, Magee D, Hird AE, Luckenbaugh AN, Ma M, Hall ME, Huelster H, Laviana AA, Davis N, Terris MK, Klaassen Z, Wallis CJD. Assessment of gender representation in Clinical Trials leading to FDA Approval for Oncology Therapeutics between 2014 and 2019: A Meta-analysis. Cancer 2021; 127(17):3156-3162. doi:10.1002/cncr.33533. Role: senior author.

Joyce D, Wallis CJD, Luckenbaugh AN, Huelster HL, Zhao Z, Hoffman KE, Huang LC, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function. Prostate Cancer Prostatic Dis 2022; 25(238-247. doi: 10.1038/s41391-021-00405-5. Role: co-author.

Wallis CJD, Shayegan B, Morgan SC, Hamilton RJ, Cagiannos I, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Roy S, Noonan KL, Niazi T, Hotte SJ, Saad F, Hew H, Chan KFY, Park-Wyllie L, Malone S. Prognostic association between common laboratory tests and overall survival in elderly de novo metastatic castration sensitive prostate cancer: a population-based study in Canada. Cancers 2021, 13(11):2844. https://doi.org/10.3390/cancers13112844. Role: primary author.

Wallis CJD, Klaassen Z, Jackson WC, Dess RT, Reichert ZR, Sun Y, Spratt DE. Olaparib versus cabazitaxel in metastatic castration resistant prostate cancer: Network-analysis of the PROfound and CARD phase 3 randomized trials. JAMA Netw Open 2021, 4(5):2110950. doi:10.1001/jamanetworkopen.2021.10950. Role: primary author.

Wallis CJD, Poon SJ, Lai P, Podczerwinki Li, Buntin MB. Trends in Medicare spending across strata of resource utilization among older individuals in the Unites States. EClinicalMedicine 2021; 36:100873. doi: https://doi.org/10.​1016/​j.​eclinm.​2021.​100873. Role: primary author.

Hall ME, Bhindi B, Luckenbaugh AN, Laviana AA, Moses KA, Satkunasivam R, Rini B, Klaassen Z, Wallis CJD. Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach. Cancer Causes Control 2021; 32(7):675-680. doi: https://doi.org/10.1007/s10552-021-01435-z. Role: senior author.

Sayyid RK, Lokeshwar SD, Luckenbaugh AN, Hall ME, Jones CE, Magee D, Hird AE, Terris MK, Klaassen Z, Wallis CJD. Women as Authors of Randomized Controlled Trials of Minimally Invasive Surgery: A Systematic Review and Meta-Analysis of Three Decades of Trials. J Am Coll Surg 2021; 233(2):167-175.e9. doi:10.1016/j.jamcollsurg.2021.03.036. Role: senior author.

Vigil HR, Wallis CJD, Zhang B, LaBossiere JR, Carr LK, Herschorn S. Stress Incontinence Surgery Does Not Cause Pelvic Malignancy: A Population-based Cohort Study. J Urol 2021; 205(6):1725-1732. doi: https://doi.org/10.1097/JU.0000000000001631. Role: primary methodologist.

COVIDSurg Collaborative and GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Brit J Surg 2021; 108(9):1056-1063. doi: https://doi.org/10.1093/bjs/znab101. Role: co-author/contributor.

Sayyid RK, Reed WC, Benton JZ, Lodh A, Woodruff P, Lambert JH, Terris MK, Wallis CJD*, Klaassen Z*. Pathologic Upgrading in Favorable Intermediate Risk Active Surveillance Patients: Clinical Heterogeneity and Implications for Active Surveillance Decision. Urol Oncol 2021; 39(11):782.e7-782.e14. doi: https://doi.org/10.1016/j.urolonc.2021.02.017. * = authors contributed equally. Role: co-senior author.

Benidir T, Herrera Caceres J, Wallis CJD, Lajkosz K, Fleshner N. Population based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer. Cancer Med 2021; 10:2636-44. doi:10.1002/cam4.3805. Role: primary methodologist.

COVIDSurg Collaborative and GlobalSurg Collaborative. Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study. Anaesthesia 2021; 76(6):748-758. doi: https://doi.org/10.1111/anae.15458. Role: co-author/contributor.

Woon DTS, Finelli A, Cheung DC, Martin LJ, Alibhai S, Wallis CJD, Diong C, Saskin R, Fleshner N. A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide. Urol 2021; 153:147-155. DOI:10.1016/j.urology.2020.11.080. Role: co-author.

Sayyid RK, Klotz L, Benton JZ, Lodh A, Hiffa A, Lokeshwar S, Madi R, Goldberg H, Terries MK, Wallis CJD*, Klaassen Z*. Influence of Sociodemographic Factors on Definitive Intervention Among Very Low- and Low-Risk Active Surveillance Patients. Urol 2021; 155:117-123. DOI:10.1016/j.urology.2021.01.053  * = authors contributed equally. Role: co-senior author.

Jazzar U, Shan Y, Bergerot CD, Wallis CJD, Freedland SJ, Kamat AM, Tyler DS, Baillargeon J, Kuo YF, Klaassen Z, Williams SB. Use of Psychotropic Drugs Among Older Patients with Bladder Cancer in the United States. Psycho-Oncol 2021;30(6):832-843. doi:10.1002/pon.5641. Role: co-author.

Klaassen Z, Wallis CJD. Assessing Patient Risk from Cancer and COVID-19: Managing Patient Distress. Urol Oncol 2021; 9(5): 243-246. doi:10.1016/j.urolonc.2021.01.023. Role: senior author.

Chandresekar T, Han TM, Glick L, Leong JY, Teplitsky S, Noorani R, Goldberg H, Klaassen Z, Wallis CJD, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Setting the Standards: Examining Research Productivity amongst Academic Urologists in the United States and Canada in 2019. Eur Urol Focus 2021; 7(2):489-96. doi: 10.1016/j.euf.2020.02.003. Role: co-author.

Pathak R, Lopes GDL, Yu H, Ji W, Aryal MR, Frumento KS, Wallis CJD, Klaassen Z, Park HS, Goldberg SB. Comparative Efficacy of Chemoimmunotherapy versus Immunotherapy Alone in the Front-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. Cancer 2021; 127(5):709-19. DOI:10.1002/cncr.33269. Role: co-author.

Goldberg H, Noorani R, Benton JZ, Lodh A, Berlin A, Chandrasekar T, Wallis CJD, Ahmad AE, Klaassen Z, Fleshner NE. Is There an Association between a History of Military Service and Cancer Diagnosis? Results from a US National Level Study of Self-Reported Outcomes. Cancer Causes Control 2021; 32(1):47-55. DOI:10.1007/s10552-020-01355-4. Role: co-author.

Goldberg H, Mohsin FK, Berlin A, Chandrasekar T, Wallis CJD, Klaassen Z, Ahmad AE, Saskin R, Kenk M, Saarela O, Kulkarni GS, Alibhai SMH, Fleshner N. The suggested chemopreventative association of metformin with prostate cancer in diabetic patients. Urol Oncol 2021; 39:191.e17-24. DOI:10.1016/j.urolonc.2020.08.032. Role: co-author.

Wallis CJD, Sayyid RK, Manyevitch R, Perlis N, Lokeshwar VB, Fleshner NF, Terris MK, Nielsen ME, Klaassen Z. Diagnostic utility of axial imaging in the evaluation of hematuria: a systematic review and critical appraisal of the literature. Can Assoc Urol J 2021; 15(2):48-55. DOI:10.5489/cuaj.6522. Role: primary author and primary methodologist.

Garbens A*, Wallis CJD*, Klaassen Z, Saskin R, Plumptre L, Kodama RT, Herschorn S, Nam RK. Comprehensive assessment of the morbidity of renal mass biopsy: a population-based assessment of biopsy-related complications. Can Assoc Urol J 2021; 15(2):42-7. DOI:10.5489/cuaj.6477. * = authors contributed equally. Role: co-primary author and primary methodologist.

Sui W, Wallis CJD, Luckenbaugh AN, Barocas DA, Chang SS, Penson DF, Resnick MJ, Laviana AA. The impact of hospital volume on short-term and long-term outcomes for patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urology 2021; 147:135-142. doi: 10.1016/j.urology.2020.07.062. Role: co-author.

Sayyid R, Wilson B, Benton J, Lodh A, Thomas E, Goldberg H, Madi R, Terris M, Wallis CJD*, Klaassen Z*. Upgrading on Radical Prostatectomy Specimens of Very Low- and Low-Risk Prostate Cancer Patients on Active Surveillance: A Population-Level Analysis. Can Assoc Urol J 2021; 15(7):E335-9 DOI: 10.5489/cuaj.6868. * = authors contributed equally. Role: co-senior author.

Sayyid RK, Magee DE, Hird AE, Harper BT, Webb E, Fratino K, Terris MK, Madi R, Satkunasivam R, Wallis CJD*, Klaassen Z*. Reoperation within 30 Days of Radical Cystectomy: Identifying High-Risk Patients and Complications Using ACS-NSQIP Database. Can Assoc Urol J 2021;15(1):E1-5. DOI:10.5489/cuaj.6490. * = authors contributed equally. Role: co-senior author and primary methodologist.

Sayyid RK, Lokeshwar SD, Tella D, Jones CE, Klaassen Z, Wallis CJD. Absence of a Positive Outcome Bias in Randomized Controlled Trials of Minimally Invasive Surgical Techniques. J Clin Epi 2021; 131:163-5. doi: 10.1016/j.jclinepi.2020.11.022. Role: senior author.

Goldberg H, Glicksman R, Woon D, Hoffman AJ, Hina SH, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad A, Noelia SS, Qu MX, Ynoede Moraes F, Diamandis E, Berlin A, Fleshner N. Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer? BJU International 2021; 127(6):654-664. doi:10.1111/bju.15236. Role: co-author.

Larcher A, Wallis CJD, Pavan N, Bertolo R, Porpiglia F, Takagi T, Tanabe K, Rha KH, Raheem AA, Yang B, Zang C, Perdona S, Quarto G, Maurer T, Amiel T, Schips L, Castellucci R, Crivellaro S, Dobbs R, Celia A, De Concilio B, Furlan M, Lima E, Linares E, Micali S, Hampton LJ, Tracey A, Amparore D, De Naeyer G, Trombetta C, Antonelli A, Montorsi F, Derweesh I, Mir C, Mottrie A, Autorino R, Capitanio U. Outcomes of Minimally Invasive Partial Nephrectomy Among Elderly Patients: Analysis from The RESURGE Collaborative International Database. Cent European J Urol 2020; 72:273-279. doi:10.5173/ceju.2020.0179. Role: co-author.

Wallis CJD, Catto JWF, Finelli A, Glaser AW, Gore JL, Loeb S, Morgan TM, Morgans AK, Mottet N, Neal R, O’Brien T, Odisho AY, Powles T, Skolarus TA, Smith AB, Szabados B, Klaassen Z, Spratt DE. The Impact of the Covid-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future. Eur Urol 2020; 78:731-742. https://doi.org/10.1016/j.eururo.2020.08.030. Role: primary author. 

Juvet T, Mari A, Lajkosz K, Wallis CJD, Kuk C, Erlich A, Krimus L, Fleshner NE, Kulkarni GS, Zlotta AR. Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of non muscle invasive bladder cancer after BCG failure. Urol Oncol 2020;38:850.e9-850.e15. https://doi.org/10.1016/j.urolonc.2020.06.031. Role: co-author and primary methodologist.

Goldberg H, Moshin F, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis C, Chandrasekar T, Klaassen Z, Penn L, Alibhai SMH, Fleshner NE. The association between proton pump inhibitors and prostate cancer specific death – a population based cohort study. Prost Can Prost Dis 2020;23:622-629. doi: 10.1038/s41391-020-0248-9. Role: co-author.

Goldberg H, Moshin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Klaassen Z, Chandrasekar T, Ahmad AE, Sayyid RK, Saarela O, Penn L, Alibhai S, Fleshner N. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer. Eur Urol Focus 2020 (e-published 30 June). doi:10.1016/j.euf.2020.06.005. Role: co-author.

Cheung DC, Wallis CJD, Possee S, Tajzler C, Anidjar M, Barrett K, Deklaj T, Drachenberg D, Evans H, French C, Gotto G, Izard J, Jain U, Kawakami J, Kulkarni GS, Lee J, McCracken J, McGregor T, Richard P, Rowe N, Sabbagh R, St. Martin B, Tatzel S, Touma N, Widmer H, Wiesenthal J, Yang B, Zorn KC, Kapoor A, Finelli A, Satkunasivam R. Canadian Consensus for Intra-Operative Hemostasis During Minimally Invasive Partial Nephrectomy. Can Assoc Urol J 2020; 14(9):E387-93.https://doi.org/10.5489/cuaj.6579. Role: co-author.

Stone BV, Feng D, Klaassen Z, Barocas DA, Wallis CJD. Comment on “Responsibilities and Expectations: Considerations of Disclosure of Overlapping Operations”. Ann Surg 2020 (e-published 9 June). DOI: 10.1097/SLA.0000000000004016. Role: senior author.

Leong JY, Chandrasekar T, Berlin A, Klaassen Z, Wallis CJD, Ahmad A, Herrera-Caceres J, Perlis N, Fleshner N, Goldberg H. Predictors of PSA testing in men aged 55 and older: A Cross-Sectional Study Based on Patient-Reported Outcomes. Int J Urol2020; 27(9):711-718. doi:10.1111/iju.14276. Role: co-author.

McKay RR, Feng FY, Wang AY, Wallis CJD, Moses KA. Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions. American Society of Clinical Oncology Educational Book 2020; 40 (e-published May 14): 1-12. doi: 10.1200/EDBK_279459. Role: co-author.

Bhindi B, Lokeshwar SD, Klaassen Z, Klotz L, Wallis CJD. Systematic review and meta-analysis of trials evaluating the role of adjuvant radiation after radical prostatectomy for prostate cancer. Can Assoc Urol J 2020;14(10):330-6. https://doi.org/10.5489/cuaj.6440. Role: senior author and primary methodologist.

Wallis CJD, Novara G, Marandino L, Bex A, Kamat AM, Karnes RJ, Morgan TM, Mottet N, Gillessen S, Bossi A, Roupret M, Powles T, Necchi A, Catto JWF, Klaassen Z. Risks from deferring treatment for genitourinary cancers: A collaborative review to aid triage and management during the COVID-19 pandemic. Eur Urol 2020; 78(1):29-42. https://doi.org/10.1016/j.eururo.2020.04.063. Role: primary author.

Hall ME, Huelster HL, Luckenbaugh AN, Laviana AA, Keegan KA, Klaassen Z, Moses KA, Wallis CJD. Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape. OncoTargets Ther 2020;13:3571-3581. https://doi.org/10.2147/OTT.S228355. Role: senior author.

Satkunasivam R, Klaassen Z, Ravi B, Fok K-H, Menser T, Kash B, Miles BJ, Bass B, Detsky AD, Wallis CJD. Association between surgeon age and post-operative outcomes: a population-based cohort study. CMAJ 2020; 192:E385-92. doi:10.1503/cmaj.190820. Role: senior author and primary methodologist.

Goldberg H, Ajaj R, Herrera-Caceres JO, Berlin A, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad AE, Leao R, Petrella AR, Kachura JR, Fleshner N, Matthew A, Finelli A, Jewett MAS, Hamilton RJ. Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass. Urol Oncol 2020; 38(6):603.e17-25. https://doi.org/10.1016/j.urolonc.2020.02.015. Role: co-author.

Benton JZ, Lodh A, Watson AM, Tingen M, Terris MK, Wallis CJD, Klaassen Z. The association between physician trust and desire for smoking cessation: Implications for motivational interviewing. Prev Med 2020; 135:106075. https://doi.org/10.1016/j.ypmed.2020.106075. Role: co-author.

Lenardis M, Harper B, Satkunasivam R, Klaassen Z, Wallis CJD. The association between patient body mass index and perioperative outcomes following radical cystectomy: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database. Can Urol Assoc J 2020; 14(9):e412-7. http://dx.doi.org/10.5489/cuaj.6243. Role: senior author and primary methodologist.

LaBossiere J, Wallis CJD, Herschorn S, Carr L, Saskin R, Nam RK. Surgical management of benign prostatic obstruction: 20-year population-level trends. Can Urol Assoc J 2020; 14(8):252-7. https://doi.org/10.5489/cuaj.6224. Role: co-author and primary methodologist.

Goldberg H, Spratt D, Chandrasekar T, Klaassen Z, Wallis C, Santiago-Jiminez M, Fishbane N, Davicioni E, Noorani R, Ahmad A, Herrera Caceres JO, Alibhai S, Zlotta A, Finelli A, Berlin A, Fleshner NF. Clinical-genomic characterization unveils more aggressive disease in elderly prostate cancer patient with low-grade disease. Eur Urol Focus 2021; 7(4):797-806. https://doi.org/10.1016/j.euf.2020.02.008. role: co-author.

Hird AE, Magee DE, Bhindi B, Ye XY, Chandrasekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z, Wallis CJD. A Systematic Review and Network Meta-Analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer 2020; 18(5):343-350. https://doi.org/10.1016/j.clgc.2020.02.005. Role: senior author and primary methodologist.

Wallis CJD, Lawson K, Butaney M, Satkunasivam R, Parikh J, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z. Association between PD-L1 status and immune checkpoint inhibitor response in advanced malignancies: a systematic review and meta-analysis of overall survival data. Jpn J Clin Oncol 2020; 50(7):800-9. doi:10.1093/jjco/hyaa021. Role: primary author and primary methodologist.

Ajaj R, Herrera Caceres JO, Berlin A, Wallis CJD, Chandresekar T, Klaassen Z, Ahmad AE, Leao R, Fleshner N, Finelli A, Goldberg H. Gender-based Psychological and Physical Distress Differences in Patients diagnosed with Non-Metastatic Renal Cell Carcinoma. World J Urol 2020; 38:2547-2554. doi:10.1007/s00345-019-03057-2. Role: co-author.

Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD. Comparison of MRI- and TRUS-informed prostate biopsy for prostate cancer diagnosis in biopsy-naïve men: a systematic review and meta-analysis. J Urol 2020; 203(6):1085-1093. doi:10.1097/JU.0000000000000595. Role: senior author and primary methodologist.

Magee D, Hird AE, Klaassen Z, Sridhar S, Nam RK, Wallis CJD, Kulkarni GS. Adverse event profile for immunotherapy agents compared to chemotherapy in solid organ tumours: a systematic review and meta-analysis of randomized clinical trials. Ann Oncol 2020; 31(1):50-60. doi:10.1016/j.annonc.2019.10.008. Role: co-author.

Wallis CJD, Klaassen Z, Luckenbaugh AN, Laviana AA, Bhindi B. Adjuvant versus salvage radiotherapy following radical prostatectomy: meta-analysis of the effect of comparator salvage approach on study conclusions. Eur Urol 2020; 77:395-396. doi:10.1016/j.eururo.2019.11.005. Role: primary author and primary methodologist.

Wallis CJD*, Garbens A*, Klaassen Z, Kodama RT, Herschorn S, Nam RK. Effect of renal mass biopsy on subsequent nephrectomy outcomes: a population-based assessment. Eur Urol 2020; 77(1):136-137. doi:10.1016/j.eururo.2019.09.025. * = authors contributed equally. Role: primary author.

Atchia KS, Wallis CJD, Fleshner N, Toren P. Switching from a GnRH agonist to a GnRH antagonist in prostate cancer patients: a systematic review and meta-analysis. Can Urol Assoc J 2020;14(2):36-41. http://dx.doi.org/10.5489/cuaj.5996. Role: primary methodologist.

Chandrasekar T, Goldberg H, Klaassen Z, Wallis CJ, Leong JY, Teplitsky S, Liem S, Noorani R, Loeb S. Twitter and Academic Urology in the United States and Canada: A Comprehensive Assessment of the Twitter-verse in 2019. BJU Int 2020; 125(1):172-181. doi:10.1111/bju.14920. Role: co-author.

Butaney M, Satkunasivam R, Goldberg H, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z*, Wallis CJD*. Analysis of heterogeneity in survival benefit of immunotherapy in oncology according to patient demographics and performance status: a systematic review and meta-analysis of overall survival data. * = authors contributed equally. Am J Clin Oncol 2020; 43(3):193-202. doi:10.1097/COC.0000000000000650. Role: senior author and primary methodologist.

Matta R, Dvorani E, Wallis CJD, Hird AE, LaBossiere, Kulkarni GS, Kodama RT, Carr L, Radomski SB, Saskin R, Herschorn S, Nam RK. Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada. BMJ Open 2019; 9(12):e032170. doi:10.1136/bmjopen-2019-032170. Role: co-author.

Fralick M, Schneewiss S, Wallis CJD, Jung E, Kesselheim AS. Desmopressin and the risk of hyponatremia: a population-based cohort study. PLoS Med 2019; 16(10): e1002930. doi.org/10.1371/journal.pmed.1002930. Role: co-author.

Hahn A*, Klaassen Z*, Agarwal N, Haaland B, Esther J, Ye XY, Wang X, Pal SK**, Wallis CJD**. First-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. Eur Urol Oncol 2019; 2(6):708-715. https://doi.org/10.1016/j.euo.2019.09.002. Role: senior author and primary methodologist. * = authors contributed equally. ** = authors contributed equally. Role: senior author and primary methodologist.

Lam TBL*, MacLennan S*, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell’Oglio P, Deschamps A, Donaldson J, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Gross T, Grummet JP, Henry AM, Ingels A, Irani J, Lardas M, Liew M, Lin DW, Moris L, Omar MI, Pang KH, Paterson C, Renard-Penna R, Ribal MJ, Roupret M, Rouvière O, Sancho-Pardo G, Richenberg J, Schoots IG, Sedelaar MJP, Stricker P, Tilki D, Vahr S, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, VAN Leenders AGJLH, Varma M, Violette PD, Wallis CJD, Wiegel T, Wilkinson, Zattoni F, N’Dow JMO, Van Poppel H, Mottet N. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study). Eur Urol 2019; 76(6):790-813. doi:10.1016/j.eururo.2019.09.020. * = authors contributed equally. Role: co-author.

Ajaj R, Berlin A, Klaassen Z, Chandrasekar T, Wallis CJD, Ahmad AE, Gentile A, Fleshner N, Zlotta A, Matthew A, Kulkarni GS, Goldberg H. Age differences in patient-reported psychological and physical distress symptoms in bladder cancer patients – A Cross Sectional Study. Urology 2019; 134:154-162. doi: 10.1016/j.urology.2019.08.032. Role: co-author.

Wallis CJD, Satkunasivam R, Butaney M, Khan UA, Goldberg H, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z. Association between smoking and survival benefit of immunotherapy in advanced malignancies: a systematic review and meta-analysis. Am J Clin Oncol 2019; 42(9):711-716. doi: 10.1097/COC.0000000000000577. Role: primary author and primary methodologist.

Goldberg H, Wallis CJD, Klaassen Z, Chandrasekar T, Fleshner N, Zlotta A. Lynch syndrome in urologic malignancies – what does the urologist need to know? Urology 2019; 134:24-31. doi: 10.1016/j.urology.2019.07.004. Role: co-author.

Nam RK, Benatar T, Wallis CJD, Kobylecky E, Amemiya Y, Seth A. MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL. The Prostate2019;79:1422-1438. doi: 10.1002/pros.23871. Role: primary methodologist.

Larcher A*, Wallis CJD*, Bex A, Blute ML, Ficarra V, Mejean A, Karam JA, Van Poppel H, Pal SK. Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?  Eur Urol Oncol 2019; 2(4): 365-378. https://doi.org/10.1016/j.euo.2019.04.007. * = authors contributed equally. Role: co-primary author.

Wettstein MS, Rooprai JK, Pazhepurackel C, Wallis CJD, Klaassen Z, Uleryk EM, Hermanns T, Fleshner NE, Zlotta AR, Kulkarni GS. Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: does the current quality of evidence justify definitive conclusions? PloS One 2019;14(4):e0216255. doi:10.1371/journal.pone.0216255. Role: co-author.

Klaassen Z*, Wallis CJD*, Chandrasekar T, Goldberg H, Sayyid R, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P**, Kulkarni GS**. Cancer diagnosis and risk of suicidal death after accounting for pre-diagnosis psychiatric care: a matched-cohort study of patients with incident solid organ malignancies. Cancer 2019; 125(16):2886-2895. https://doi.org/10.1002/cncr.32146. * = authors contributed equally; ** = authors contributed equally. Role: co-primary author.

Klaassen Z, Wallis CJD, Lavallee L, Violette P. Perioperative venous thromboembolism prophylaxis in prostate cancer surgery. World J Urol 2020; 38:593-600. doi: 10.1007/s00345-019-02705-x. Role: co-author.

Klaassen Z*, Wallis CJD*, Goldberg H, Chandrasekar T, Sayyid R, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P**, Kulkarni GS**. The Impact of Psychiatric Utilization prior to Cancer Diagnosis on survival of solid organ malignancies: a population-level analysis in Ontario, Canada. Brit J Cancer 2019; 129(8):840-847.https://doi.org/10.1038/s41416-019-0390-0. * = authors contributed equally; ** = authors contributed equally. Role: co-primary author

.

Goldberg H, Cheung DC, Chandresekar T, Klaassen Z, Wallis CJD, Kulkarni GS, Sayyid R, Evans A, Masoomian M, Bapat B, Van der Kwast T, Hamilton RJ, Zlotta A, Fleshner N. Are there differences between de novo and secondary upper tract urothelial carcinoma tumors? Can Urol Assoc J 2019 13(9):E292-9. https://doi.org/10.5489/cuaj.5595. Role: co-author.

Wallis CJD, Butaney M, Satkunasivam R, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z. Association of patient sex with efficacy of immune checkpoint inhibitors and overall survival in advanced cancers: A systematic review and meta-analysis. JAMA Onc 2019; 5(4):529-536. doi:10.1001/jamaoncol.2018.5904. Role: primary author and primary methodologist.

Chandrasekar T, Goldberg H, Klaassen Z, Wallis CJD, Woon DTS, Herrera-Caceres JO, Kulkarni GS, Fleshner NE. The who, when and why of primary adrenal malignancies: insights into the epidemiology of a rare clinical entity. Cancer 2019; 125(7):1050-1059. doi:10.1002/cncr.31916. Role: co-author.

Garbens A, Wallis CJD, Matta R, Kodama R, Herschorn S, Narod S, Nam RK. The cost of treatment and its related complications for men who receive surgery or radiation therapy for prostate cancer. Can Urol Assoc 2019; 13(8):E236-48. doi:10.5489/cuaj.5598. Role: primary methodologist.

Klaassen Z, Wallis CJD, Fleshner N. Abiraterone acetate for non-metastatic castration-resistant prostate cancer: the forgotten dance partner? JAMA Onc 2019; 5(2):144-5. doi:10.1001/jamaoncol.2018.5191. Role: co-author.

Satkunasivam R, Tallman CT, Taylor JM, Miles BJ, Klaassen Z, Wallis CJD. Robot-assisted radical cystectomy versus open radical cystectomy: a meta-analysis of peri-operative, complication-related and oncologic outcomes. Eur Urol Oncol 2019; 2(4): 443-447. doi:10.1016/j.euo.2018.10.008. Role: senior author and primary methodologist.

Matta R, Wallis CJD, Hird A, Klaassen Z, Kulkarni GS, Kodama RT, Herschorn S, Nam RK. Variation and trends in antidepressant prescribing for men undergoing treatment for nonmetastatic prostate cancer: a population-based cohort study. Eur Urol 2019; 75(1):3-7. https://doi.org/10.1016/j.eururo.2018.08.035. Role: co-author.

Goldberg H, Ramiz A-H, Glicksman R, Chandesekar T, Klaassen Z, Wallis CJD, Hosni A, Fleshner N, Moraes FY, Kulkarni GS, Hamilton RJ, Chung P, Perlis N, Finelli A, Van der Kwast T, Evans A, Berlin A. Extra-prostatic extension in core biopsies epitomized high-risk but locally-treatable prostate cancer. Eur Urol Oncol 2019; 2:88-96. doi: 10.1016/j.euo.2018.05.003. Role: co-author.

Feinberg A, Wallis CJD, Nam RK, Hameed U. Survival and peri-operative outcomes among patients with rectal cancer: the role of prior prostate cancer and radiotherapy. Int J Colorectal Dis 2019; 34(1):97-104. doi:10.1007/s00384-018-3175-7. Role: primary methodologist.

Wallis CJD, Detsky AS, Fan E. Establishing the effectiveness of procedural interventions: the limited role of randomized trials. JAMA2018; 320(23):2421-2422. doi:10.1001/jama.2018.16329. Role: primary author.

Radomski SB, Ruzhynsky V, Wallis CJD, Herschorn S. Complications and interventions in patients with artificial urinary sphincters: long-term results. J Urol 2018; 200(5):1093-1098. doi:10.1016/j.juro.2018.05.143. Role: primary methodologist.

Goldberg H, Klaassen Z, Chandrasekar T, Wallis CJD, Toi A, Sayyid R, Bhindi B, Nesbitt M, Evans A, Van der Kwast T, Sweet J, Perlis N, Hamilton RJ, Kulkarni GS, Finelli A, Zlotta A, Fleshner N. Evaluation of an aggressive prostate biopsy strategy in men younger than 50 years of age. J Urol 2018; 200(5):1056-1061. doi: 10.1016/j.juro.2018.05.017. Role: co-author.

Jeong Y, Mahar AL, Coburn N, Wallis CJD, Satkunasivam R, Beyfuss K, Karanicolas P, Law C, Hallet J. Outcomes of non-curative gastrectomy for gastric cancer: an analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Ann Surg Oncol 2018; 25(13):3943-3949. doi:10.1245/s10434-018-6824-8. Role: co-author.

Klaassen Z*, Wallis CJD*, Goldberg H, Chandrasekar T, Fleshner NF, Finelli A, Kulkarni GS, Detsky AS, Satkunasivam R. The association between patient’s trust in their physicians and PSA screening: implications for shared decision making. Can Urol Assoc J 2018; 12(12): 395-400. http://dx.doi.org/10.5489/cuaj.5351 * = authors contributed equally. Role: co-primary author.

Wallis CJD, Chandresekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z. Advanced androgen blockage in non-metastatic castration resistant prostate cancer: an indirect comparison of apalutamide and enzalutamide. Eur Urol Oncol 2018; 1(3):238-241. doi:10.1016/j.euo.2018.04.004. Role: primary author and primary methodologist.

Welk B, Wallis CJD, D’Souza D, McGee J, Nam RK. A population-based assessment of the long-term urologic and bowel complications of pelvic radiation and surgery for cervical cancer. Int J Gynecol Cancer 2018 (e-published 16 April). doi: 10.1097/IGC.0000000000001266. Role: primary methodologist.

Wallis CJD*, Klaassen Z*, Bhindi B, Ye XY, Chandrasekar T, Farrell AM, Goldberg H, Boorjian SA, Leibovich B, Kulkarni GS, Shah PS, Heng D, Satkunasivam R, Finelli A. First-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysis. Eur Urol 2018; 74(3):309-321. doi: 10.1016/j.eururo.2018.03.036 * = authors contributed equally. Role: co-primary author and primary methodologist.

Nam RK, Wallis CJD, Amemiya Y, Benatar T, Seth A. Identification of a novel microRNA panel associated with metastasis following radical prostatectomy for prostate cancer. Anticancer Res 2018; 38(9):5027-5034. doi:10.21873/anticanres.12821. Role: primary methodologist.

Wallis CJD, Satkunasivam R, Herschorn S, Law C, Seth A, Kodama RT, Kulkarni GS, Nam RK. Null association between androgen deprivation therapy and non-prostate cancer mortality among men with non-metastatic prostate cancer. Urol Oncol 2018; 36(5):241.e1-241.e6. doi:10.1016/j.urolonc.2018.02.001. Role: primary author and primary methodologist.

Bhindi B, Wallis CJD, Boorjian S, Thompson RH, Farrell AM, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. BJU Int2018; 121(5): 684-698. doi:10.1111/bju.14127. Role: primary methodologist.

Klaassen Z, Goldberg H, Chandrasekar T, Hamilton RJ, Fleshner NE, Williams SB, Wallis CJD, Kulkarni GS. Changing trends for suicidal death in patients with bladder cancer: A 40+ year population-level analysis. Clin Genitourin Cancer 2018; 16(3):206-212e1. doi:10.1016/j.clgc.2017.12.016. Role: co-author.

Wallis CJD, Morton G, Herschorn S, Kodama RT, Kulkarni GS, Shayegan B, Buckley R, Grabowski A, Danjoux C, Narod SA, Nam RK. The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation. Br J Cancer 2018; 118(10): 1399-1405. doi:10.1038/s41416-018-0071-4. Role: primary author and primary methodologist.

Wallis CJD*, Klaassen Z*, Bhindi B, Goldberg H, Chandrasekar T, Farrell AM, Boorjian SA, Kulkarni GS, Karnes RJ, Satkunasivam R. Comparison of abiraterone acetate and docetaxel with androgen deprivation therapy in high risk and metastatic hormone-naïve prostate cancer: a systematic review and network meta-analysis. Eur Urol 2018; 73(6): 834-844. doi: 10.1016/j.eururo.2017.10.002 * = authors contributed equally. Role: co-primary author and primary methodologist.

Nam RK, Benatar T, Amemiya Y, Wallis CJD, Romero J, Tsagaris M, Sherman C, Sugar L, Seth A. MicroRNA-652 induces NED in LNCAP and EMT in PC3 prostate cancer cells. Oncotarget 2018; 9(27):19159-19176. doi:10.18632/oncotarget.24937. Role: primary methodologist.

Wallis CJD, Satkunasivam R, Herschorn S, Law C, Seth A, Kodama RT, Kulkarni GS, Nam RK. Association between primary local treatment and non-prostate cancer mortality in men with non-metastatic prostate cancer. Urology 2018; 114:147-154. doi:10.1016/j.urology.2017.12.013. Role: primary author and primary methodologist.

Wallis CJD, Satkunasivam R, Saskin R, Bansal S, Emmenegger U, Nam RK. Population-based analysis of treatment toxicity among men with castrate-resistant prostate cancer. Urology 2018; 113:138-145. doi:10.1016/j.urology.2017.08.067. Role: primary author and primary methodologist.

Klaassen Z, Arora K, Goldberg H, Chandrasekar T, Wallis CJD, Sayyid RK, Fleshner NE, Kutikov A, Finelli A, Violette PD, Kulkarni GS. Extended venous thromboembolism prophylaxis after radical cystectomy: Rationale for standardized care. J Urol 2018; 199(4):906-914. doi:10.1016/j.juro.2017.08.130. Role: co-author.

Wallis CJD*, Cheung DC*, Klotz L, Chalasani V, Leao R, Garisto J, Morton G, Nam RK, Tannock I, Satkunasivam R. Personal PSA screening and treatment choices for localized prostate cancer among expert surgeons. Can Urol Assoc J 2018; 12(2):59-63. http://dx.doi.org/10.5489/cuaj.4736. * = authors contributed equally. Role: co-primary author.

Wallis CJD, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D, Murphy D, Nguyen P, Resnick M, Nam RK. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review. Eur Urol2018; 73(1):11-20. doi: 10.1016/j.eururo.2017.05.055. Role: primary author.

Garbens A, Goldenberg M, Wallis CJD, Tricco AC, Grantcharov TP. The cost of intraoperative adverse events in abdominal surgery: a systematic review and meta-analysis. Am J Surg 2018; 215(1):163-170. doi: 10.1016/j.amjsurg.2017.06.025. Role: co-author.

Wallis CJD, Peltz S, Byrne J, Kroft J, Karanicolas P, Nam RK, Hallet J, Satkunasivam R. Role of Minimally-Invasive Surgery in Peripheral Nerve Injury during Abdominal-Pelvic Surgery – Analysis of the National Surgical Quality Improvement Program Database. Am Surg 2017; 83(11):1214-1219. Role: primary author and primary methodologist.

Wallis CJD, Ravi B, Coburn N, Ellison L, Saskin R, Nam RK, Detsky AS, Satkunasivam R. Comparison of outcomes among patients treated by male and female surgeons. The BMJ 2017;359:j4366. doi:10.1136/bmj.j4366. Role: primary author and primary methodologist.

Wallis CJD, Juvet T, Lee Y, Matta R, Satkunasivam R, Herschorn S, Kodama RT, Kulkarni GS, Geerts W, McLeod A, Narod SA, Nam RK. Association between use of antithrombotic medications and hematuria-related complications. JAMA 2017;318(13):1260-1271. doi: 10.1001/jama.2017.13890. Role: primary author and primary methodologist.

Garbens A, Wallis CJD, Bjarnason G, Kulkarni GS, Nathens AB, Nam RK, Satkunasivam R. Platelet to white blood cell ratio predicts 30-days post-operative infection complications in patients undergoing radical nephrectomy for renal malignancy. Can Urol Assoc J 2017; 11(11):E414-420. http://dx.doi.org/10.5489/cuaj.4478. Role: primary methodologist.

Goldenberg M, Nabhani J, Wallis CJD, Chopra S, Schucman A, Djaladat H, Daneshmand S, Desai MM, Aron M, Gill IS, Satkunasivam R. Feasibility of Expert and Crowd Sourced Review of Intraoperative Video for Quality Improvement of Intra-Corporeal Urinary Diversion During Robotic Radical Cystectomy. Can Urol Assoc J 2017; 11(10):331-336. http://dx.doi.org/10.5489/cuaj.4442. Role: co-author.

Wallis CJD, Saskin R, Narod SA, Law C, Kulkarni GS, Seth A, Nam RK. Estimating the effect of immortal-time bias in urologic research. BJU Int 2017; 120(4):584-590. doi:10.1111/bju.13918. Role: primary author and primary methodologist.

Bhindi B*, Wallis CJD*, Nayan M, Farrell AM, Trost LW, Hamilton RJ, Kulkarni GS, Finelli A, Fleshner NE, Boorjian SA, Karnes RJ. The association between vasectomy and prostate cancer: a systematic review and meta-analysis. JAMA Intern Med2017;177(9):1273-1286. doi:10.1001/jamainternmed.2017.2791. * = authors contributed equally. Role: co-primary author and primary methodologist.

Wallis CJD, Khana S, Hajiha M, Nam RK, Satkunasivam R. Radical cystectomy in patients with disseminated disease: an assessment of peri-operative outcomes using the National Surgical Quality Improvement Program database. Can Urol Assoc J 2017; 11(8):244-8. doi: http://dx.doi.org/10.5489/cuaj.4208. Role: primary author and primary methodologist.

Wallis CJD, Morton G, Jerath A, Satkunasivam R, Szumacher E, Naimark D, Nam RK. Adjuvant versus salvage radiotherapy for patients with adverse prognostic findings following radical prostatectomy: a decision analysis. Med Decis Making Policy & Practice 2017 (e-published 19 May). doi: 10.1177/2381468317709476. Role: primary author.

Wallis CJD, Haider M, Nam RK. Role of mpMRI of the prostate in screening for prostate cancer. Transl Androl Urol 2017; 6(3):464-471. doi: 10.21037/tau.2017.04.31. Role: primary author.

Wallis CJD*, Garbens A*, Chopra S, Gill IS, Satkunasivam R. Robotic partial nephrectomy: expanding utilization, advancing innovation. J Endourol 2017; 31(4):348-354. doi:10.1089/end.2016.0639. * = authors contributed equally. Role: co-primary author.

Wang LI, Wallis CJD, Sathianathen N, Lawrentschuk N, Murphy D, Nam RK, Moon D. ‘ProtecTion’ from overtreatment – does a randomised trial finally answer the key question in localised prostate cancer? BJU Int 2017; 119(4):513-514.doi:10.1111/bju.13734. Role: co-author.

Satkunasivam R, Wallis CJD, Byrne J, Hoffman A, Cheung D, Nathens AB, Nam RK. Peri-operative outcomes following radical prostatectomy for patients with disseminated cancer – an analysis of the National Surgical Quality Improvement Program Database. Can Urol Assoc J 2016;10(11-12):423-429. doi:10.5489/cuaj.3939. Role: primary methodologist.

Wallis CJD*, Cheung DC*, Garbens A, Kroft J, Carr L, Nathens AB, Nam RK, Liu G, Gien L, Satkunasivam R. Occurrence of and Risk Factors for Urological Intervention During Benign Hysterectomy – Analysis of the National Surgical Quality Improvement Program Database. Urology 2016; 97:66-72. 

doi: http://dx.doi.org/10.1016/j.urology.2016.06.037 * = authors contributed equally. Role: co-primary author and primary methodologist.

Wallis CJD, Mahar AL, Satkunasivam R, Herschorn S, Kodama RT, Lee Y, Kulkarni GS, Narod SA, Nam RK. Cardiovascular and skeletal-related events in older men treated for localised prostate cancer: the role of surgery, radiotherapy and androgen-deprivation therapy. Urology 2016; 97:145-152. http://dx.doi.org/10.1016/j.urology.2016.08.002. Role: primary author.

Wallis CJD, Mahar A, Cheung P, Herschorn S, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Hospitalizations to manage complications of modern prostate cancer treatment in older men. Urology 2016; 96:142-147. doi: http://dx.doi.org/10.1016/j.urology.2016.05.054. Role: primary author.

Wallis CJD, Downes MR, Bjarnason G, Satkunasivam R. Isolated Brain Metastasis from a Small Renal Mass. BMJ Case Rep 2016; E-published. doi:10.1136/bcr-2016-216081. Role: primary author.

Satkunasivam R, Wallis CJD, Nam RK, Desai M, Gill IS. Contemporary Evidence for Robotic Radical Cystectomy. Nat Rev Urol 2016; 13:533-539. doi:10.1038/nrurol.2016.139. Role: co-author.

Wallis CJD, Bjarnason G, Byrne J, Cheung D, Hoffman A, Nathens AB, Nam RK, Satkunasivam R. Morbidity and mortality of radical nephrectomy for patients with disseminated cancer – an analysis of the National Surgical Quality Improvement Program Database. Urology 2016; 95:95-102. http://dx.doi.org/10.1016/j.urology.2016.04.055. Role: primary author and primary methodologist.

Wallis CJD, Lundeen C, Golda L, Brotherhood H, Pommerville P, Carr L. Anticholinergics for overactive bladder: temporal trends in prescription and treatment persistence. Can Urol Assoc J 2016; 10(7-8):277-280. http:dx.doi.org/10.5489/cuaj3526. Role: primary author and primary methodologist.

Nam RK, Wallis CJD, Stojcic-Bendavid, J, Milot L, Sherman C, Sugar L, Haider MA. A Pilot Study of the Magnetic Resonance Imaging for Prostate Cancer. J Urol 2016; 196(2):361-365. doi:10.1016/j.juro.2016.01.114. Role: co-author.

Wallis CJD, Lo K, Lee Y, Krakowsky Y, Garbens A, Satkunasivam R, Herschorn S, Kodama RT, Cheung P, Narod SA, Nam RK. Survival and cardiovascular events among men treated with testosterone replacement therapy: an intent-to-treat observational cohort study. Lancet Diabetes Endocrinol 2016; 4(6):498-506. http://dx.doi.org/10.1016/S2213-8587(16)00112-1. Role: primary author and primary methodologist.

Nam RK, Benatar T, Wallis CJD, Amemiya Y, Yang W, Garbens A, Naeim M, Sherman C, Sugar L, Seth A. MiR-301a regulates e-cadherin expression and is predictive of prostate cancer recurrence. The Prostate 2016; 76:869-884. doi:10.1002/pros.23177. Role: primary methodologist.

Wallis CJD, Mahar AL, Choo R, Herschorn S, Kodama RT, Shah PS, Danjoux C, Narod SA, Nam RK. Secondary malignancies following radiotherapy for prostate cancer: a systematic review and meta-analysis. The BMJ 2016; 352:i851. doi:10.1136/bmj.i851. Role: primary author and primary methodologist.

Almatar A, Wallis CJD, Herschorn S, Saskin R, Kulkarni GS, Kodama RT, Nam RK. Effect of Radical Prostatectomy Surgeon Volume on Complication Rates from a Large Population-Based Cohort. Can Urol Assoc J 2016; 10(1-2):45-9. doi:10.5489/cuaj.3214. Role: co-author.

Wallis CJD, Saskin R, Choo R, Herschorn S, Kodama RT, Satkunasivam R, Shah PS, Danjoux C, Nam RK. Surgery versus radiotherapy for prostate cancer: a systematic review and meta-analysis. Eur Urol 2016; 70(1):21-30. doi:10.1016/j.eururo.2015.11.010. Role: primary author and primary methodologist.

Wallis CJD, Mahar AL, Cheung P, Herschorn S, Klotz LH, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Examination of New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men. Eur Urol 2016; 69(5):933-41. doi:10.1016/j.eururo.2015.10.043. Role: primary author.

Wallis CJD*, Gordanpour A*, Nam RK, Stojcic Bendavid J, Sugar L, Seth A. MiR-182 is associated with growth, migration and invasion in prostate cancer via suppression of FOXO1. J Cancer 2015; 6(12):1295-1305. doi:10.7150/jca.13176. * = authors contributed equally. Role: co-primary author and primary methodologist.

Nam RK, Amemiya Y, Benatar T, Wallis CJD, Stojcic-Bendavid J, Bacopulos S, Sherman C, Sugar L, Naeim M, Yang W, Zhang A, Klotz LH, Narod SA, Seth A. Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: a cohort study. J Cancer 2015; 6(11):1160-1171. doi:10.7150/jca.13397. Role: co-author.

Wallis CJD, Nam RK. Prostate Cancer Genetics: A review. Electronic Journal of the International Federation of Clinical Chemistry 2015: 26(2):79-91. PMID: 27683484. Role: primary author.

Wallis CJD, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, Kulkarni GD, Lee Y, Kodama RT, Narod SA, Nam RK. Complications Following Surgery with or without Radiotherapy or Radiotherapy Alone for Prostate Cancer. Br J Cancer 2015; 112:977-982. doi:10.1038/bjc.2015.54. Role: primary author.

Wallis CJD, Herschorn S, Saskin R, Su J, Klotz LH, Chang M, Kulkarni GD, Lee Y, Kodama RT, Narod SA, Nam RK. Complications Following Radical Prostatectomy or Radiotherapy for Prostate Cancer: Results of a Population-based, Propensity-score Matched Analysis. Urology 2015; 85(3):621-628. 

doi:10.1016/j.urology.2014.11.037. Role: primary author.

Wallis CJD, Herschorn S, Liu Y, Carr LK, Kodama RT, Klotz LH, Saskin R, Nam RK. Practice patterns of post-radical prostatectomy incontinence surgery. Can Urol Assoc J 2014; 8(9-10):e670-674. doi:10.5489/cuaj.1959. Role: primary author.

Akbari MR, Wallis CJD, Toi A, Trachtenberg J, Sun P, Narod SA, Nam RK. The Impact of a BRCA2 Mutation on Mortality from Screen-Detected Prostate Cancer. Br J Cancer 2014; 111:1238-1240. doi:10.1038/bjc.2014.428. Role: co-author.

Wallis CJD, Nelson HL, Pommerville PJ. Testosterone deficiency syndrome and cardiovascular health: An assessment of beliefs, knowledge, and practice patterns of general practitioners and cardiologists in Victoria BC. Can Urol Assoc J 2014; 8(1-2):30-33. doi:10.5489/cuaj.1448. Role: primary author.

Wallis CJD, English JC, Goldenberg SL. The role of resection of a solitary pulmonary metastasis from prostate cancer: A case report and literature review. Can Urol Assoc J 2011; 5(6):E104-E108. doi:10.5489/cuaj.10136. Role: primary author.

Nelson HL, Wallis CJD, Pommerville PJ. Isolated Tuberculous epididymitis: A rare complication after intravesical Bacillus Calmette-Guerin therapy. Current Urology 2011; 5(2):106-108. Role: primary author.

El-Zammar D, Yan M, Huang C, Fang D, Petigara F, Bornn L, Ngai T, Brkanovic S, Khangura J, Alexander N, Hendry S, Lubin J, Wallis C, Ford J, Kapoor V. Assessment and management of anemia in a population of children living in the Indian Himalayas: A student-led initiative. University of British ColumRoy S, Sun Y, Wallis CJD, Morgan S, Grimes S, Malone J, Kishan A, Mukerjee D, Spratt D, Saad F, Malone S. Association of Dynamic Change in Patient-reported Pain with Survival in Metastatic Castrate Sensitive Prostate Cancer – Exploratory Analysis of LATITUDE Study. Prostate Cancer Prostatic Dis 2022 (e-published 13 September). Doi: 10.1038/s41391-022-00529-2. Role: co-author.

Klaassen Z, Howard L, Wallis CJD, De Hoedt A, Aronson W, Polascik L, Amling C, Kane C, Cooperberg M, Terris, Wu Y, Freedland S, Janes J. Is Time to Castration Resistant Prostate Cancer a Potential Intermediate End-Point for Time to Metastasis Among Men Initiating Androgen Deprivation Therapy for Non-Metastatic Prostate Cancer with Rapid PSA Doubling Time (<9 Months)? Prostate Cancer Prostatic Dis 2022 (e-published 1 September). doi:10.1038/s41391-022-00585-8. Role: co-author.

De B, Pasalic D, Barocas DA, Wallis CJD, Huang JC, Zhao Z, Koyama T, Tang C, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Kaplan SH, Greenfield S, Penson DF, Hoffman K. Patient-Reported Outcomes after External Beam Radiotherapy with Low Dose-Rate Brachytherapy Boost versus Radical Prostatectomy for Localized Prostate Cancer: Five-Year Results from a Prospective Comparative Effectiveness Study. J Urol 2022 (e-published 25 August). doi:10.1097/JU.0000000000002902. Role: co-author.

Sayyid RK, Hiffa A, Woodruff P, Oberle MD, Lambert JH, Terris MK, Wallis CJD, Klaassen Z. Suspension of Oncology Randomized Clinical Trials During the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions. Cancer Investigation. 2022; 40(9): 743-749. https://doi.org/10.1080/07357907.2022.2104305. Role: co-author.

Roy S*, Sayyid R*, Saad F, Sun Y, Lajkosz K, Ong M, Klaassen Z, Malone S, Spratt DE, Wallis CJD**, Morgan SC**. Addition of Docetaxel to Androgen Receptor Axis-Targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone Sensitive Prostate Cancer: A Network Meta-Analysis. Eur Urol Oncol 2022 (e-published 7 July). *=co-first author. **=co-senior author. doi: https://doi.org/10.1016/j.euo.2022.06.003. Role: co-senior author.

Roy S, Sun Y, Wallis CJD, Morgan S, Grimes S, Malone J, Kishan A, Mukerjee D, Spratt D, Saad F, Malone S. Development and Validation of a Multivariable Prognostic Model in de novo Metastatic Castrate Sensitive Prostate Cancer. Prostate Cancer Prostatic Dis 2022 (e-published 5 July). doi: https://doi.org/10.1038/s41391-022-00560-3. Role: co-author.

Satkunasivam R, Lim K, The BS, Guzman J, Zhang J, Farach A, Chen SH, Wallis CJD, Efstathiou E, Esnaola NF, Sonpavde G. A Phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin ineligible muscle invasive bladder cancer: the RAD VACCINE MIBC Trial. Future Oncology 2022 (e-published 15 June). doi: https://doi.org/10.2217/fon-2022-0380. Role: co-author.

Launer BM, Sayyid RK, Klaassen Z, Whelan E, Magee DE, Luckenbaugh AN, Wallis CJD. On the Shoulders of Giants: Correlation of Rates of Female First Authorship with Senior Authorship Gender. Brit J Surg 2022 (e-published 6 June). DOI: 10.1093/bjs/znac163. Role: senior author.

Wallis CJD, Jerath A, Kaneshwaran K, Hallet J, Coburn N, Wright FC, Gotlib-Coon L, Bischoff D, Covelli A, Klaassen Z, Zlotta AR, Kulkarni GS, Luckenbaugh AN, Armstrong K, Lim K, Bass B, Detsky AS, Satkunasivam R. Association between surgeon and anesthesiologist sex discordance and postoperative outcomes: a population-based cohort study. Ann Surg 2022; 276(1):81-7. DOI: 10.1097/SLA.0000000000005495. Role: primary author.

Malone S, Wallis CJD, Lee-Ying R, Basappa NS, Cagiannos I, Hamilton RJ, Fernandes R, Ferrario C, Gotto GT, Morgan SC, Morash C, Niazi T, Noonan KL, Rendon R, Hotte SJ, Saad F, Zardan A, Osborne B, Chan KFY, Shayegan B. Patterns of Care for Patients with Non-metastatic Castration-Resistant Prostate Cancer: Population-based Study in Canada. BJUI Compass 2022; 3(5):383-391. doi: 10.1002/bco2.158. Role: co-author and primary methodologist.

Manogue CE, Chen W, Mazza A, Dang A, Lewis B, Wallis CJD, Layton J, Barata P, Sartor O, Harris KM. Embracing the Practical Aspects of Theranostics with PSMA-Targeted Lutetium-177. Pract Radiat Oncol 2022 (e-published 14 May). https://doi.org/10.1016/j.prro.2022.01.008. Role: co-author.

Dursun F, Lim K, Svatek RS, Xu J, El-Zaatari Z, Wenker E, Klaassen Z, Muhammed T, Efsathiou E, Sonpavade G, Wallis CJD, Satkunasivam R. Clinical Outcomes and Patterns of Population Based Management of Urachal Carcinoma: An analysis of the National Cancer Database. Cancer Med 2022 (e-published 4 May). DOI: 10.1002/cam4.4786. Role: co-author.

Lee SG, Fralick J, Wallis CJD, Boctor M, Sholzberg M, Fralick M. Systematic review of Hematuria and Acute Renal failure with tranexamic acid. Eur J Haematol 2022;108(6):510-517. DOI: 10.1111/ejh.13762. Role: co-author. 

Celtik K, Wallis CJD, Lo M, Lim K, Lipscomb J, Fleming S, Wu XC, Anderson RT, Thompson TD, Farach A, Hamilton AS, Miles BJ, Satkunasivam R. Mortality Following Radical Prostatectomy or Intensity Modulated Radiation Therapy for Localized Prostate Cancer – An Analysis of the CDC Breast and Prostate Cancer Data Quality and Patterns of Care Study (CDC PoC-BP). Can Urol Assoc J 2021 (e-published 28 February). http://dx.doi.org/10.5489/cuaj.7580. Role: co-author and primary methodologist.

Tallman JE, Wallis CJD, Huang JC, Zhao Z, Penson D, Koyama T, Conwill R, Goodman M, Hamilton A, Wu XC, Paddock L, Stroup A, Cooperberg M, Hashibe M, O’Neil B, Kaplan S, Greenfield S, Barocas D, Hoffman K. Association between adherence to radiation therapy quality metrics and patient reported outcomes in prostate cancer. Prostate Cancer Prostatic Dis 2022 (e-published 25 February). https://doi.org/10.1038/s41391-022-00518-5. Role: co-author and primary methodologist.

Shayegan B, Wallis CJD, Malone S, Cagiannos I, Hamilton RJ, Ferrario C, Gotta GT, Basappa NS, Morgan SC, Fernandes R, Morash C, Niazi T, Noonan KL, Rendon R, Osborne B, Park-Wyllie L, Chang KFY, Hotte SJ, Saad F. Real-World Use of Systemic Therapies in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) in Canada. Urol Oncol 2022 (e-published 23 February). doi: 10.1016/j.urolonc.2022.01.009. Role: co-author and primary methodologist.

Shayegan B, Wallis CJD, Hamilton RJ, Morgan SC, Cagiannos I, Basappa NS, Ferrario C, Gotta GT, Fernandes R, Roy S, Noonan KL, Niazi T, Hotte SJ, Saad F, Hew H, Park-Wyllie L, Chang KFY Malone S. Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in Canada. Prostate Cancer Prostatic Dis 2022 (e-published 23 February). doi:10.1038/s41391-022-00514-9. Role: co-author, primary methodologist, and corresponding author.

Klaassen Z, Assel MJ, Vickers AJ, Vertosick E, Novara G, Pierce C, Wallis CJD, Larcher A, Cooperberg MR, Catto JWF, Kutikov, A. Optimal Dissemination of Scientific Manuscripts via Social Media: A Prospective Trial Comparing Visual Abstracts Versus Key Figures in Consecutive Original Manuscripts Published in European Urology. Eur Urol 2022 (e-published 9 February).https://doi.org/10.1016/j.eururo.2022.01.041. Role: co-author.

Celtik K, Lim K, Dursun F, Xu J, Klaassen Z, Zhang J, Efstathiou E, Sonpavade G, Wallis CJD, Satkunasivam R. Association between perioperative chemotherapy and survival in men undergoing radical resection for primary urethral urothelial carcinoma: An Analysis of the National Cancer Database. Clin Genitourin Cancer 2022 (e-published 27 January). doi:10.1016/j.clgc.2022.01.011. Role: co-author and primary methodologist.

Luckenbaugh AN, Wallis CJD, Huang LC, Wittman D, Klaassen Z, Zhao Z, Koyama T, Laviana AA, Conwill R, Goodman M, Hamilton A, Qu XC, Paddock L, Stroup A, Cooperberg M, Hashibe M, O’Neil B, Kaplan S, Greenfield S, Hoffman K, Penson D, Barocas DA. Association between treatment for localized prostate cancer and mental health outcomes. J Urol 2022; 207:1029-1037. doi:10.1097/JU.0000000000002370. Role: co-author and primary methodologist.

Tiwari R, Lajkosz K, Fleshner N, Wallis CJD. Have we mis-PRONOUNCEd the cardiovascular risk of GnRH agonists? A critical appraisal of the PRONOUNCE trial. Prostate Cancer Prostatic Dis 2022 (4 January). https://doi.org/10.1038/s41391-021-00483-5. Role: senior author.

Wallis CJD, Jerath A, Coburn N, Klaassen Z, Luckenbaugh AN, Magee DE, Hird AE, Armstrong K, Ravi B, Esnaola NF, Guzman JCA, Bass B, Detsky AS, Satkunasivam R. Association between surgeon-patient sex concordance and post-operative outcomes: a population-based cohort study. JAMA Surgery 2022; 157(2):146-156. doi:10.1001/jamasurg.2021.6339. Role: primary author.

Wallis CJD, Zhao Z, Huang LC, Penson DF, Koyama T, Kaplan S, Greenfield S, Luckenbaugh AN, Klaassen Z, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Hoffman KE, Barocas DA. Treatment-related regret among men with localized prostate cancer: understanding the contribution of treatment modality, functional outcomes, and baseline characteristics. JAMA Oncology 2022; 8(10):50-59. doi:10.1001/jamaoncol.2021.5160. Role: primary author.

Lee MC, Erickson TR, Stock S, Howard LE, De Hoedt AM, Amling CL, Aronson WJ, Cooperberg MR, Kane CJ, Terris MK, Klaassen Z, Freedland SJ, Wallis CJD. Association between delay to radical prostatectomy and clinically meaningful outcomes among patients with intermediate- and high-risk localized prostate cancer. J Urol 2022; 207(3):592-600. doi:10.1097/JU.0000000000002304. Role: senior author.

Satkunasivam R, Guzman JCA, Klaassen Z, Hall ME, Luckenbaugh AN, Lim K, Laviana AA, DeRose AP, Beckermann KE, Rini B, Wallis CJD. Association between prior nephrectomy and efficacy of immune checkpoint inhibitor therapy in metastatic renal cell carcinoma – a systematic review and meta-analysis. Urol Oncol 2022; 40(2):64e17-64.e24. doi: https://doi.org/10.1016/j.urolonc.2021.09.009. Role: senior author and primary methodologist.

Sui W, Hall ME, Barocas DA, Chang SS, Luckenbaugh AN, Moses KA, Penson DF, Wallis CJD, Laviana AA. Association between surgical volume and survival among patients with variant histologies of bladder cancer. Urology 2022; 159:p100-106. doi: https://doi.org/10.1016/j.urology.2021.09.009. Role: primary methodologist.

Dursun F, Mackay A, Guzman JCA, Wenker E, Klaassen Z, O’Malley P, Bhindi B, Obando Perez C, Xu J, Roh T, Sonpavade G, Wallis CJD, Satkunasivam R. Utilization and Outcomes of Metastasectomy for Patients with Metastatic Urothelial Cancer: An Analysis of the National Cancer Database. Urol Oncol 2022; 40(2):61.e21-61.e28. https://doi.org/10.1016/j.urolonc.2021.07.015. Role: primary methodologist.

COVIDSurg Collaborative and GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia 2022; 77(1):28-39. doi: https://doi.org/10.1111/anae.15563. Role: co-author/contributor.

Wallis CJD, Huang LC, Zhao Z, Penson DF, Koyama T, Conwill R, Tallman JE, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Kaplan SH, Greenfield S, Barocas DA, Hoffman KE. Association between pelvic nodal radiotherapy and patient-reported functional outcomes through 5 years among men undergoing external-beam radiotherapy for prostate cancer: an assessment of the CEASAR cohort. Urol Oncol 2022; 40(2): 56.e1-56.e8. https://doi.org/10.1016/j.urolonc.2021.04.035. Role: primary author.

Sayyid RK, Lokeshwar SD, Tella D, Jones CE, Oberle MD, Woodruff P, Klaassen Z, Wallis CJD. Transparency of Racial Participation Reporting in Randomized Controlled Trials of Minimally Invasive Surgical Techniques. Surg Endosc 2022; 36:2600-2606. doi:10.1007/s00464-021-08550-7. Role: senior author.

Goldberg H, Mohsin FK, Chandrasekar T, Wallis CJD, Klaassen Z, Ahmad AE, Saskin R, Kenk M, Saarela O, Kulkarni GS, Alibhai SMH, Fleshner N. The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy. Can Urol Assoc J 2022; 16(5):e248-e255. doi: 10.5489/cuaj.7464. Role: co-author.

Wallis CJD, Malone S, Cagiannos I, Morgan SC, Hamilton RJ, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Niazi T, Noonan KL, Saad F, Hotte SJ, Hew H, Chan KFY, Park Wyllie L, Shayegan B. Real-World Utilization of Androgen Deprivation Therapy-Intensification Among Older Canadian Men With de novo Metastatic Prostate Cancer. JNCI Cancer Spectr 2021 (e-published 1 October). doi: https://doi.org/10.1093/jncics/pkab082. Role: primary author.

Poon SJ, Wallis CJD, Lai P, Podczerwinski L, Buntin MD. Medicare Two-Midnight Rule Accelerated Shift to Observation Stays. Health Aff 2021; 40(11): 1688-1696. doi: 10.1377/hlthaff.2021.00094. Role: co-author.

Wallis CJD*, Joyce DD*, Klaassen Z, Luckenbaugh AN, Laviana AA, Penson D, Dusetzina SB, Barcoas DA. Out-of-pocket costs for commercially insured patients with localized prostate cancer. Urol Oncol 2021; 39(12):797-805. doi: https://doi.org/10.1016/j.urolonc.2021.08.026. * = authors contributed equally. Role: co-primary author and primary methodologist.

Sayyid RK, Klotz L, Benton JZ, Ma M, Woodruff P, Satkunasivam R, Terris MK, Wallis CJD*, Klaassen Z*. Active Surveillance in Favorable Intermediate Risk Prostate Cancer Patients: Predictors of Deferred Intervention and Choice of Treatment. Can Urol Assoc J 2021; 16(1):e7-14. doi: https://doi.org/10.5489/cuaj.7272. * = authors contributed equally. Role: co-senior author.

Anassie J, Dursun F, Wallis CJD, Klaassen Z, Obando-Perez C, Xu S, Boone T, Khavari R, Satkunasivam R. Dissecting the Role of Radical Cystectomy and Urinary Diversion in Post-Operative Complications: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database. Int Braz J Urol. 2021; 47(5):1006-1019. doi: 10.1590/S1677-5538.IBJU.2020.1098. Role: co-author.

Dymanus K, Butaney M, Magee D, Hird AE, Luckenbaugh AN, Ma M, Hall ME, Huelster H, Laviana AA, Davis N, Terris MK, Klaassen Z, Wallis CJD. Assessment of gender representation in Clinical Trials leading to FDA Approval for Oncology Therapeutics between 2014 and 2019: A Meta-analysis. Cancer 2021; 127(17):3156-3162. doi:10.1002/cncr.33533. Role: senior author.

Joyce D, Wallis CJD, Luckenbaugh AN, Huelster HL, Zhao Z, Hoffman KE, Huang LC, Koyama T, Conwill R, Goodman M, Hamilton AS, Wu XC, Paddock LE, Stroup A, Cooperberg MR, Hashibe M, O’Neil BB, Kaplan SH, Greenfield S, Penson DF, Barocas DA. Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline function. Prostate Cancer Prostatic Dis 2022; 25(238-247. doi: 10.1038/s41391-021-00405-5. Role: co-author.

Wallis CJD, Shayegan B, Morgan SC, Hamilton RJ, Cagiannos I, Basappa NS, Ferrario C, Gotto GT, Fernandes R, Roy S, Noonan KL, Niazi T, Hotte SJ, Saad F, Hew H, Chan KFY, Park-Wyllie L, Malone S. Prognostic association between common laboratory tests and overall survival in elderly de novo metastatic castration sensitive prostate cancer: a population-based study in Canada. Cancers 2021, 13(11):2844. https://doi.org/10.3390/cancers13112844. Role: primary author.

Wallis CJD, Klaassen Z, Jackson WC, Dess RT, Reichert ZR, Sun Y, Spratt DE. Olaparib versus cabazitaxel in metastatic castration resistant prostate cancer: Network-analysis of the PROfound and CARD phase 3 randomized trials. JAMA Netw Open 2021, 4(5):2110950. doi:10.1001/jamanetworkopen.2021.10950. Role: primary author.

Wallis CJD, Poon SJ, Lai P, Podczerwinki Li, Buntin MB. Trends in Medicare spending across strata of resource utilization among older individuals in the Unites States. EClinicalMedicine 2021; 36:100873. doi: https://doi.org/10.​1016/​j.​eclinm.​2021.​100873. Role: primary author.

Hall ME, Bhindi B, Luckenbaugh AN, Laviana AA, Moses KA, Satkunasivam R, Rini B, Klaassen Z, Wallis CJD. Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach. Cancer Causes Control 2021; 32(7):675-680. doi: https://doi.org/10.1007/s10552-021-01435-z. Role: senior author.

Sayyid RK, Lokeshwar SD, Luckenbaugh AN, Hall ME, Jones CE, Magee D, Hird AE, Terris MK, Klaassen Z, Wallis CJD. Women as Authors of Randomized Controlled Trials of Minimally Invasive Surgery: A Systematic Review and Meta-Analysis of Three Decades of Trials. J Am Coll Surg 2021; 233(2):167-175.e9. doi:10.1016/j.jamcollsurg.2021.03.036. Role: senior author.

Vigil HR, Wallis CJD, Zhang B, LaBossiere JR, Carr LK, Herschorn S. Stress Incontinence Surgery Does Not Cause Pelvic Malignancy: A Population-based Cohort Study. J Urol 2021; 205(6):1725-1732. doi: https://doi.org/10.1097/JU.0000000000001631. Role: primary methodologist.

COVIDSurg Collaborative and GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Brit J Surg 2021; 108(9):1056-1063. doi: https://doi.org/10.1093/bjs/znab101. Role: co-author/contributor.

Sayyid RK, Reed WC, Benton JZ, Lodh A, Woodruff P, Lambert JH, Terris MK, Wallis CJD*, Klaassen Z*. Pathologic Upgrading in Favorable Intermediate Risk Active Surveillance Patients: Clinical Heterogeneity and Implications for Active Surveillance Decision. Urol Oncol 2021; 39(11):782.e7-782.e14. doi: https://doi.org/10.1016/j.urolonc.2021.02.017. * = authors contributed equally. Role: co-senior author.

Benidir T, Herrera Caceres J, Wallis CJD, Lajkosz K, Fleshner N. Population based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer. Cancer Med 2021; 10:2636-44. doi:10.1002/cam4.3805. Role: primary methodologist.

COVIDSurg Collaborative and GlobalSurg Collaborative. Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study. Anaesthesia 2021; 76(6):748-758. doi: https://doi.org/10.1111/anae.15458. Role: co-author/contributor.

Woon DTS, Finelli A, Cheung DC, Martin LJ, Alibhai S, Wallis CJD, Diong C, Saskin R, Fleshner N. A population-based study comparing outcomes for patients with metastatic castrate resistant prostate cancer treated by urologists or medical oncologists with first line abiraterone acetate or enzalutamide. Urol 2021; 153:147-155. DOI:10.1016/j.urology.2020.11.080. Role: co-author.

Sayyid RK, Klotz L, Benton JZ, Lodh A, Hiffa A, Lokeshwar S, Madi R, Goldberg H, Terries MK, Wallis CJD*, Klaassen Z*. Influence of Sociodemographic Factors on Definitive Intervention Among Very Low- and Low-Risk Active Surveillance Patients. Urol 2021; 155:117-123. DOI:10.1016/j.urology.2021.01.053  * = authors contributed equally. Role: co-senior author.

Jazzar U, Shan Y, Bergerot CD, Wallis CJD, Freedland SJ, Kamat AM, Tyler DS, Baillargeon J, Kuo YF, Klaassen Z, Williams SB. Use of Psychotropic Drugs Among Older Patients with Bladder Cancer in the United States. Psycho-Oncol 2021;30(6):832-843. doi:10.1002/pon.5641. Role: co-author.

Klaassen Z, Wallis CJD. Assessing Patient Risk from Cancer and COVID-19: Managing Patient Distress. Urol Oncol 2021; 9(5): 243-246. doi:10.1016/j.urolonc.2021.01.023. Role: senior author.

Chandresekar T, Han TM, Glick L, Leong JY, Teplitsky S, Noorani R, Goldberg H, Klaassen Z, Wallis CJD, Mark JR, Trabulsi EJ, Lallas CD, Gomella LG. Setting the Standards: Examining Research Productivity amongst Academic Urologists in the United States and Canada in 2019. Eur Urol Focus 2021; 7(2):489-96. doi: 10.1016/j.euf.2020.02.003. Role: co-author.

Pathak R, Lopes GDL, Yu H, Ji W, Aryal MR, Frumento KS, Wallis CJD, Klaassen Z, Park HS, Goldberg SB. Comparative Efficacy of Chemoimmunotherapy versus Immunotherapy Alone in the Front-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. Cancer 2021; 127(5):709-19. DOI:10.1002/cncr.33269. Role: co-author.

Goldberg H, Noorani R, Benton JZ, Lodh A, Berlin A, Chandrasekar T, Wallis CJD, Ahmad AE, Klaassen Z, Fleshner NE. Is There an Association between a History of Military Service and Cancer Diagnosis? Results from a US National Level Study of Self-Reported Outcomes. Cancer Causes Control 2021; 32(1):47-55. DOI:10.1007/s10552-020-01355-4. Role: co-author.

Goldberg H, Mohsin FK, Berlin A, Chandrasekar T, Wallis CJD, Klaassen Z, Ahmad AE, Saskin R, Kenk M, Saarela O, Kulkarni GS, Alibhai SMH, Fleshner N. The suggested chemopreventative association of metformin with prostate cancer in diabetic patients. Urol Oncol 2021; 39:191.e17-24. DOI:10.1016/j.urolonc.2020.08.032. Role: co-author.

Wallis CJD, Sayyid RK, Manyevitch R, Perlis N, Lokeshwar VB, Fleshner NF, Terris MK, Nielsen ME, Klaassen Z. Diagnostic utility of axial imaging in the evaluation of hematuria: a systematic review and critical appraisal of the literature. Can Assoc Urol J 2021; 15(2):48-55. DOI:10.5489/cuaj.6522. Role: primary author and primary methodologist.

Garbens A*, Wallis CJD*, Klaassen Z, Saskin R, Plumptre L, Kodama RT, Herschorn S, Nam RK. Comprehensive assessment of the morbidity of renal mass biopsy: a population-based assessment of biopsy-related complications. Can Assoc Urol J 2021; 15(2):42-7. DOI:10.5489/cuaj.6477. * = authors contributed equally. Role: co-primary author and primary methodologist.

Sui W, Wallis CJD, Luckenbaugh AN, Barocas DA, Chang SS, Penson DF, Resnick MJ, Laviana AA. The impact of hospital volume on short-term and long-term outcomes for patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urology 2021; 147:135-142. doi: 10.1016/j.urology.2020.07.062. Role: co-author.

Sayyid R, Wilson B, Benton J, Lodh A, Thomas E, Goldberg H, Madi R, Terris M, Wallis CJD*, Klaassen Z*. Upgrading on Radical Prostatectomy Specimens of Very Low- and Low-Risk Prostate Cancer Patients on Active Surveillance: A Population-Level Analysis. Can Assoc Urol J 2021; 15(7):E335-9 DOI: 10.5489/cuaj.6868. * = authors contributed equally. Role: co-senior author.

Sayyid RK, Magee DE, Hird AE, Harper BT, Webb E, Fratino K, Terris MK, Madi R, Satkunasivam R, Wallis CJD*, Klaassen Z*. Reoperation within 30 Days of Radical Cystectomy: Identifying High-Risk Patients and Complications Using ACS-NSQIP Database. Can Assoc Urol J 2021;15(1):E1-5. DOI:10.5489/cuaj.6490. * = authors contributed equally. Role: co-senior author and primary methodologist.

Sayyid RK, Lokeshwar SD, Tella D, Jones CE, Klaassen Z, Wallis CJD. Absence of a Positive Outcome Bias in Randomized Controlled Trials of Minimally Invasive Surgical Techniques. J Clin Epi 2021; 131:163-5. doi: 10.1016/j.jclinepi.2020.11.022. Role: senior author.

Goldberg H, Glicksman R, Woon D, Hoffman AJ, Hina SH, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad A, Noelia SS, Qu MX, Ynoede Moraes F, Diamandis E, Berlin A, Fleshner N. Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer? BJU International 2021; 127(6):654-664. doi:10.1111/bju.15236. Role: co-author.

Larcher A, Wallis CJD, Pavan N, Bertolo R, Porpiglia F, Takagi T, Tanabe K, Rha KH, Raheem AA, Yang B, Zang C, Perdona S, Quarto G, Maurer T, Amiel T, Schips L, Castellucci R, Crivellaro S, Dobbs R, Celia A, De Concilio B, Furlan M, Lima E, Linares E, Micali S, Hampton LJ, Tracey A, Amparore D, De Naeyer G, Trombetta C, Antonelli A, Montorsi F, Derweesh I, Mir C, Mottrie A, Autorino R, Capitanio U. Outcomes of Minimally Invasive Partial Nephrectomy Among Elderly Patients: Analysis from The RESURGE Collaborative International Database. Cent European J Urol 2020; 72:273-279. doi:10.5173/ceju.2020.0179. Role: co-author.

Wallis CJD, Catto JWF, Finelli A, Glaser AW, Gore JL, Loeb S, Morgan TM, Morgans AK, Mottet N, Neal R, O’Brien T, Odisho AY, Powles T, Skolarus TA, Smith AB, Szabados B, Klaassen Z, Spratt DE. The Impact of the Covid-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future. Eur Urol 2020; 78:731-742. https://doi.org/10.1016/j.eururo.2020.08.030. Role: primary author. 

Juvet T, Mari A, Lajkosz K, Wallis CJD, Kuk C, Erlich A, Krimus L, Fleshner NE, Kulkarni GS, Zlotta AR. Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of non muscle invasive bladder cancer after BCG failure. Urol Oncol 2020;38:850.e9-850.e15. https://doi.org/10.1016/j.urolonc.2020.06.031. Role: co-author and primary methodologist.

Goldberg H, Moshin F, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis C, Chandrasekar T, Klaassen Z, Penn L, Alibhai SMH, Fleshner NE. The association between proton pump inhibitors and prostate cancer specific death – a population based cohort study. Prost Can Prost Dis 2020;23:622-629. doi: 10.1038/s41391-020-0248-9. Role: co-author.

Goldberg H, Moshin FK, Saskin R, Kulkarni GS, Berlin A, Kenk M, Wallis CJD, Klaassen Z, Chandrasekar T, Ahmad AE, Sayyid RK, Saarela O, Penn L, Alibhai S, Fleshner N. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer. Eur Urol Focus 2020 (e-published 30 June). doi:10.1016/j.euf.2020.06.005. Role: co-author.

Cheung DC, Wallis CJD, Possee S, Tajzler C, Anidjar M, Barrett K, Deklaj T, Drachenberg D, Evans H, French C, Gotto G, Izard J, Jain U, Kawakami J, Kulkarni GS, Lee J, McCracken J, McGregor T, Richard P, Rowe N, Sabbagh R, St. Martin B, Tatzel S, Touma N, Widmer H, Wiesenthal J, Yang B, Zorn KC, Kapoor A, Finelli A, Satkunasivam R. Canadian Consensus for Intra-Operative Hemostasis During Minimally Invasive Partial Nephrectomy. Can Assoc Urol J 2020; 14(9):E387-93.https://doi.org/10.5489/cuaj.6579. Role: co-author.

Stone BV, Feng D, Klaassen Z, Barocas DA, Wallis CJD. Comment on “Responsibilities and Expectations: Considerations of Disclosure of Overlapping Operations”. Ann Surg 2020 (e-published 9 June). DOI: 10.1097/SLA.0000000000004016. Role: senior author.

Leong JY, Chandrasekar T, Berlin A, Klaassen Z, Wallis CJD, Ahmad A, Herrera-Caceres J, Perlis N, Fleshner N, Goldberg H. Predictors of PSA testing in men aged 55 and older: A Cross-Sectional Study Based on Patient-Reported Outcomes. Int J Urol2020; 27(9):711-718. doi:10.1111/iju.14276. Role: co-author.

McKay RR, Feng FY, Wang AY, Wallis CJD, Moses KA. Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment Decisions. American Society of Clinical Oncology Educational Book 2020; 40 (e-published May 14): 1-12. doi: 10.1200/EDBK_279459. Role: co-author.

Bhindi B, Lokeshwar SD, Klaassen Z, Klotz L, Wallis CJD. Systematic review and meta-analysis of trials evaluating the role of adjuvant radiation after radical prostatectomy for prostate cancer. Can Assoc Urol J 2020;14(10):330-6. https://doi.org/10.5489/cuaj.6440. Role: senior author and primary methodologist.

Wallis CJD, Novara G, Marandino L, Bex A, Kamat AM, Karnes RJ, Morgan TM, Mottet N, Gillessen S, Bossi A, Roupret M, Powles T, Necchi A, Catto JWF, Klaassen Z. Risks from deferring treatment for genitourinary cancers: A collaborative review to aid triage and management during the COVID-19 pandemic. Eur Urol 2020; 78(1):29-42. https://doi.org/10.1016/j.eururo.2020.04.063. Role: primary author.

Hall ME, Huelster HL, Luckenbaugh AN, Laviana AA, Keegan KA, Klaassen Z, Moses KA, Wallis CJD. Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape. OncoTargets Ther 2020;13:3571-3581. https://doi.org/10.2147/OTT.S228355. Role: senior author.

Satkunasivam R, Klaassen Z, Ravi B, Fok K-H, Menser T, Kash B, Miles BJ, Bass B, Detsky AD, Wallis CJD. Association between surgeon age and post-operative outcomes: a population-based cohort study. CMAJ 2020; 192:E385-92. doi:10.1503/cmaj.190820. Role: senior author and primary methodologist.

Goldberg H, Ajaj R, Herrera-Caceres JO, Berlin A, Chandrasekar T, Klaassen Z, Wallis CJD, Ahmad AE, Leao R, Petrella AR, Kachura JR, Fleshner N, Matthew A, Finelli A, Jewett MAS, Hamilton RJ. Psychological distress associated with active surveillance in patients younger than 70 with a small renal mass. Urol Oncol 2020; 38(6):603.e17-25. https://doi.org/10.1016/j.urolonc.2020.02.015. Role: co-author.

Benton JZ, Lodh A, Watson AM, Tingen M, Terris MK, Wallis CJD, Klaassen Z. The association between physician trust and desire for smoking cessation: Implications for motivational interviewing. Prev Med 2020; 135:106075. https://doi.org/10.1016/j.ypmed.2020.106075. Role: co-author.

Lenardis M, Harper B, Satkunasivam R, Klaassen Z, Wallis CJD. The association between patient body mass index and perioperative outcomes following radical cystectomy: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database. Can Urol Assoc J 2020; 14(9):e412-7. http://dx.doi.org/10.5489/cuaj.6243. Role: senior author and primary methodologist.

LaBossiere J, Wallis CJD, Herschorn S, Carr L, Saskin R, Nam RK. Surgical management of benign prostatic obstruction: 20-year population-level trends. Can Urol Assoc J 2020; 14(8):252-7. https://doi.org/10.5489/cuaj.6224. Role: co-author and primary methodologist.

Goldberg H, Spratt D, Chandrasekar T, Klaassen Z, Wallis C, Santiago-Jiminez M, Fishbane N, Davicioni E, Noorani R, Ahmad A, Herrera Caceres JO, Alibhai S, Zlotta A, Finelli A, Berlin A, Fleshner NF. Clinical-genomic characterization unveils more aggressive disease in elderly prostate cancer patient with low-grade disease. Eur Urol Focus 2021; 7(4):797-806. https://doi.org/10.1016/j.euf.2020.02.008. role: co-author.

Hird AE, Magee DE, Bhindi B, Ye XY, Chandrasekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z, Wallis CJD. A Systematic Review and Network Meta-Analysis of Novel Androgen Receptor Inhibitors in Non-metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer 2020; 18(5):343-350. https://doi.org/10.1016/j.clgc.2020.02.005. Role: senior author and primary methodologist.

Wallis CJD, Lawson K, Butaney M, Satkunasivam R, Parikh J, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z. Association between PD-L1 status and immune checkpoint inhibitor response in advanced malignancies: a systematic review and meta-analysis of overall survival data. Jpn J Clin Oncol 2020; 50(7):800-9. doi:10.1093/jjco/hyaa021. Role: primary author and primary methodologist.

Ajaj R, Herrera Caceres JO, Berlin A, Wallis CJD, Chandresekar T, Klaassen Z, Ahmad AE, Leao R, Fleshner N, Finelli A, Goldberg H. Gender-based Psychological and Physical Distress Differences in Patients diagnosed with Non-Metastatic Renal Cell Carcinoma. World J Urol 2020; 38:2547-2554. doi:10.1007/s00345-019-03057-2. Role: co-author.

Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD. Comparison of MRI- and TRUS-informed prostate biopsy for prostate cancer diagnosis in biopsy-naïve men: a systematic review and meta-analysis. J Urol 2020; 203(6):1085-1093. doi:10.1097/JU.0000000000000595. Role: senior author and primary methodologist.

Magee D, Hird AE, Klaassen Z, Sridhar S, Nam RK, Wallis CJD, Kulkarni GS. Adverse event profile for immunotherapy agents compared to chemotherapy in solid organ tumours: a systematic review and meta-analysis of randomized clinical trials. Ann Oncol 2020; 31(1):50-60. doi:10.1016/j.annonc.2019.10.008. Role: co-author.

Wallis CJD, Klaassen Z, Luckenbaugh AN, Laviana AA, Bhindi B. Adjuvant versus salvage radiotherapy following radical prostatectomy: meta-analysis of the effect of comparator salvage approach on study conclusions. Eur Urol 2020; 77:395-396. doi:10.1016/j.eururo.2019.11.005. Role: primary author and primary methodologist.

Wallis CJD*, Garbens A*, Klaassen Z, Kodama RT, Herschorn S, Nam RK. Effect of renal mass biopsy on subsequent nephrectomy outcomes: a population-based assessment. Eur Urol 2020; 77(1):136-137. doi:10.1016/j.eururo.2019.09.025. * = authors contributed equally. Role: primary author.

Atchia KS, Wallis CJD, Fleshner N, Toren P. Switching from a GnRH agonist to a GnRH antagonist in prostate cancer patients: a systematic review and meta-analysis. Can Urol Assoc J 2020;14(2):36-41. http://dx.doi.org/10.5489/cuaj.5996. Role: primary methodologist.

Chandrasekar T, Goldberg H, Klaassen Z, Wallis CJ, Leong JY, Teplitsky S, Liem S, Noorani R, Loeb S. Twitter and Academic Urology in the United States and Canada: A Comprehensive Assessment of the Twitter-verse in 2019. BJU Int 2020; 125(1):172-181. doi:10.1111/bju.14920. Role: co-author.

Butaney M, Satkunasivam R, Goldberg H, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z*, Wallis CJD*. Analysis of heterogeneity in survival benefit of immunotherapy in oncology according to patient demographics and performance status: a systematic review and meta-analysis of overall survival data. * = authors contributed equally. Am J Clin Oncol 2020; 43(3):193-202. doi:10.1097/COC.0000000000000650. Role: senior author and primary methodologist.

Matta R, Dvorani E, Wallis CJD, Hird AE, LaBossiere, Kulkarni GS, Kodama RT, Carr L, Radomski SB, Saskin R, Herschorn S, Nam RK. Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada. BMJ Open 2019; 9(12):e032170. doi:10.1136/bmjopen-2019-032170. Role: co-author.

Fralick M, Schneewiss S, Wallis CJD, Jung E, Kesselheim AS. Desmopressin and the risk of hyponatremia: a population-based cohort study. PLoS Med 2019; 16(10): e1002930. doi.org/10.1371/journal.pmed.1002930. Role: co-author.

Hahn A*, Klaassen Z*, Agarwal N, Haaland B, Esther J, Ye XY, Wang X, Pal SK**, Wallis CJD**. First-line treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. Eur Urol Oncol 2019; 2(6):708-715. https://doi.org/10.1016/j.euo.2019.09.002. Role: senior author and primary methodologist. * = authors contributed equally. ** = authors contributed equally. Role: senior author and primary methodologist.

Lam TBL*, MacLennan S*, Willemse PM, Mason MD, Plass K, Shepherd R, Baanders R, Bangma CH, Bjartell A, Bossi A, Briers E, Briganti A, Buddingh KT, Catto JWF, Colecchia M, Cox BW, Cumberbatch MG, Davies J, Davis NF, De Santis M, Dell’Oglio P, Deschamps A, Donaldson J, Egawa S, Fankhauser CD, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Gross T, Grummet JP, Henry AM, Ingels A, Irani J, Lardas M, Liew M, Lin DW, Moris L, Omar MI, Pang KH, Paterson C, Renard-Penna R, Ribal MJ, Roupret M, Rouvière O, Sancho-Pardo G, Richenberg J, Schoots IG, Sedelaar MJP, Stricker P, Tilki D, Vahr S, van den Bergh RCN, Van den Broeck T, van der Kwast TH, van der Poel HG, VAN Leenders AGJLH, Varma M, Violette PD, Wallis CJD, Wiegel T, Wilkinson, Zattoni F, N’Dow JMO, Van Poppel H, Mottet N. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus statements for deferred treatment with curative intent for localised prostate cancer from an international collaborative study (DETECTIVE Study). Eur Urol 2019; 76(6):790-813. doi:10.1016/j.eururo.2019.09.020. * = authors contributed equally. Role: co-author.

Ajaj R, Berlin A, Klaassen Z, Chandrasekar T, Wallis CJD, Ahmad AE, Gentile A, Fleshner N, Zlotta A, Matthew A, Kulkarni GS, Goldberg H. Age differences in patient-reported psychological and physical distress symptoms in bladder cancer patients – A Cross Sectional Study. Urology 2019; 134:154-162. doi: 10.1016/j.urology.2019.08.032. Role: co-author.

Wallis CJD, Satkunasivam R, Butaney M, Khan UA, Goldberg H, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z. Association between smoking and survival benefit of immunotherapy in advanced malignancies: a systematic review and meta-analysis. Am J Clin Oncol 2019; 42(9):711-716. doi: 10.1097/COC.0000000000000577. Role: primary author and primary methodologist.

Goldberg H, Wallis CJD, Klaassen Z, Chandrasekar T, Fleshner N, Zlotta A. Lynch syndrome in urologic malignancies – what does the urologist need to know? Urology 2019; 134:24-31. doi: 10.1016/j.urology.2019.07.004. Role: co-author.

Nam RK, Benatar T, Wallis CJD, Kobylecky E, Amemiya Y, Seth A. MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL. The Prostate2019;79:1422-1438. doi: 10.1002/pros.23871. Role: primary methodologist.

Larcher A*, Wallis CJD*, Bex A, Blute ML, Ficarra V, Mejean A, Karam JA, Van Poppel H, Pal SK. Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?  Eur Urol Oncol 2019; 2(4): 365-378. https://doi.org/10.1016/j.euo.2019.04.007. * = authors contributed equally. Role: co-primary author.

Wettstein MS, Rooprai JK, Pazhepurackel C, Wallis CJD, Klaassen Z, Uleryk EM, Hermanns T, Fleshner NE, Zlotta AR, Kulkarni GS. Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: does the current quality of evidence justify definitive conclusions? PloS One 2019;14(4):e0216255. doi:10.1371/journal.pone.0216255. Role: co-author.

Klaassen Z*, Wallis CJD*, Chandrasekar T, Goldberg H, Sayyid R, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P**, Kulkarni GS**. Cancer diagnosis and risk of suicidal death after accounting for pre-diagnosis psychiatric care: a matched-cohort study of patients with incident solid organ malignancies. Cancer 2019; 125(16):2886-2895. https://doi.org/10.1002/cncr.32146. * = authors contributed equally; ** = authors contributed equally. Role: co-primary author.

Klaassen Z, Wallis CJD, Lavallee L, Violette P. Perioperative venous thromboembolism prophylaxis in prostate cancer surgery. World J Urol 2020; 38:593-600. doi: 10.1007/s00345-019-02705-x. Role: co-author.

Klaassen Z*, Wallis CJD*, Goldberg H, Chandrasekar T, Sayyid R, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P**, Kulkarni GS**. The Impact of Psychiatric Utilization prior to Cancer Diagnosis on survival of solid organ malignancies: a population-level analysis in Ontario, Canada. Brit J Cancer 2019; 129(8):840-847.https://doi.org/10.1038/s41416-019-0390-0. * = authors contributed equally; ** = authors contributed equally. Role: co-primary author

.

Goldberg H, Cheung DC, Chandresekar T, Klaassen Z, Wallis CJD, Kulkarni GS, Sayyid R, Evans A, Masoomian M, Bapat B, Van der Kwast T, Hamilton RJ, Zlotta A, Fleshner N. Are there differences between de novo and secondary upper tract urothelial carcinoma tumors? Can Urol Assoc J 2019 13(9):E292-9. https://doi.org/10.5489/cuaj.5595. Role: co-author.

Wallis CJD, Butaney M, Satkunasivam R, Freedland SJ, Patel SP, Hamid O, Pal SK, Klaassen Z. Association of patient sex with efficacy of immune checkpoint inhibitors and overall survival in advanced cancers: A systematic review and meta-analysis. JAMA Onc 2019; 5(4):529-536. doi:10.1001/jamaoncol.2018.5904. Role: primary author and primary methodologist.

Chandrasekar T, Goldberg H, Klaassen Z, Wallis CJD, Woon DTS, Herrera-Caceres JO, Kulkarni GS, Fleshner NE. The who, when and why of primary adrenal malignancies: insights into the epidemiology of a rare clinical entity. Cancer 2019; 125(7):1050-1059. doi:10.1002/cncr.31916. Role: co-author.

Garbens A, Wallis CJD, Matta R, Kodama R, Herschorn S, Narod S, Nam RK. The cost of treatment and its related complications for men who receive surgery or radiation therapy for prostate cancer. Can Urol Assoc 2019; 13(8):E236-48. doi:10.5489/cuaj.5598. Role: primary methodologist.

Klaassen Z, Wallis CJD, Fleshner N. Abiraterone acetate for non-metastatic castration-resistant prostate cancer: the forgotten dance partner? JAMA Onc 2019; 5(2):144-5. doi:10.1001/jamaoncol.2018.5191. Role: co-author.

Satkunasivam R, Tallman CT, Taylor JM, Miles BJ, Klaassen Z, Wallis CJD. Robot-assisted radical cystectomy versus open radical cystectomy: a meta-analysis of peri-operative, complication-related and oncologic outcomes. Eur Urol Oncol 2019; 2(4): 443-447. doi:10.1016/j.euo.2018.10.008. Role: senior author and primary methodologist.

Matta R, Wallis CJD, Hird A, Klaassen Z, Kulkarni GS, Kodama RT, Herschorn S, Nam RK. Variation and trends in antidepressant prescribing for men undergoing treatment for nonmetastatic prostate cancer: a population-based cohort study. Eur Urol 2019; 75(1):3-7. https://doi.org/10.1016/j.eururo.2018.08.035. Role: co-author.

Goldberg H, Ramiz A-H, Glicksman R, Chandesekar T, Klaassen Z, Wallis CJD, Hosni A, Fleshner N, Moraes FY, Kulkarni GS, Hamilton RJ, Chung P, Perlis N, Finelli A, Van der Kwast T, Evans A, Berlin A. Extra-prostatic extension in core biopsies epitomized high-risk but locally-treatable prostate cancer. Eur Urol Oncol 2019; 2:88-96. doi: 10.1016/j.euo.2018.05.003. Role: co-author.

Feinberg A, Wallis CJD, Nam RK, Hameed U. Survival and peri-operative outcomes among patients with rectal cancer: the role of prior prostate cancer and radiotherapy. Int J Colorectal Dis 2019; 34(1):97-104. doi:10.1007/s00384-018-3175-7. Role: primary methodologist.

Wallis CJD, Detsky AS, Fan E. Establishing the effectiveness of procedural interventions: the limited role of randomized trials. JAMA2018; 320(23):2421-2422. doi:10.1001/jama.2018.16329. Role: primary author.

Radomski SB, Ruzhynsky V, Wallis CJD, Herschorn S. Complications and interventions in patients with artificial urinary sphincters: long-term results. J Urol 2018; 200(5):1093-1098. doi:10.1016/j.juro.2018.05.143. Role: primary methodologist.

Goldberg H, Klaassen Z, Chandrasekar T, Wallis CJD, Toi A, Sayyid R, Bhindi B, Nesbitt M, Evans A, Van der Kwast T, Sweet J, Perlis N, Hamilton RJ, Kulkarni GS, Finelli A, Zlotta A, Fleshner N. Evaluation of an aggressive prostate biopsy strategy in men younger than 50 years of age. J Urol 2018; 200(5):1056-1061. doi: 10.1016/j.juro.2018.05.017. Role: co-author.

Jeong Y, Mahar AL, Coburn N, Wallis CJD, Satkunasivam R, Beyfuss K, Karanicolas P, Law C, Hallet J. Outcomes of non-curative gastrectomy for gastric cancer: an analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). Ann Surg Oncol 2018; 25(13):3943-3949. doi:10.1245/s10434-018-6824-8. Role: co-author.

Klaassen Z*, Wallis CJD*, Goldberg H, Chandrasekar T, Fleshner NF, Finelli A, Kulkarni GS, Detsky AS, Satkunasivam R. The association between patient’s trust in their physicians and PSA screening: implications for shared decision making. Can Urol Assoc J 2018; 12(12): 395-400. http://dx.doi.org/10.5489/cuaj.5351 * = authors contributed equally. Role: co-primary author.

Wallis CJD, Chandresekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z. Advanced androgen blockage in non-metastatic castration resistant prostate cancer: an indirect comparison of apalutamide and enzalutamide. Eur Urol Oncol 2018; 1(3):238-241. doi:10.1016/j.euo.2018.04.004. Role: primary author and primary methodologist.

Welk B, Wallis CJD, D’Souza D, McGee J, Nam RK. A population-based assessment of the long-term urologic and bowel complications of pelvic radiation and surgery for cervical cancer. Int J Gynecol Cancer 2018 (e-published 16 April). doi: 10.1097/IGC.0000000000001266. Role: primary methodologist.

Wallis CJD*, Klaassen Z*, Bhindi B, Ye XY, Chandrasekar T, Farrell AM, Goldberg H, Boorjian SA, Leibovich B, Kulkarni GS, Shah PS, Heng D, Satkunasivam R, Finelli A. First-line systemic therapy for metastatic renal cell carcinoma: a systematic review and network meta-analysis. Eur Urol 2018; 74(3):309-321. doi: 10.1016/j.eururo.2018.03.036 * = authors contributed equally. Role: co-primary author and primary methodologist.

Nam RK, Wallis CJD, Amemiya Y, Benatar T, Seth A. Identification of a novel microRNA panel associated with metastasis following radical prostatectomy for prostate cancer. Anticancer Res 2018; 38(9):5027-5034. doi:10.21873/anticanres.12821. Role: primary methodologist.

Wallis CJD, Satkunasivam R, Herschorn S, Law C, Seth A, Kodama RT, Kulkarni GS, Nam RK. Null association between androgen deprivation therapy and non-prostate cancer mortality among men with non-metastatic prostate cancer. Urol Oncol 2018; 36(5):241.e1-241.e6. doi:10.1016/j.urolonc.2018.02.001. Role: primary author and primary methodologist.

Bhindi B, Wallis CJD, Boorjian S, Thompson RH, Farrell AM, Kim SP, Karam JA, Capitanio U, Golijanin D, Leibovich BC, Gershman B. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis. BJU Int2018; 121(5): 684-698. doi:10.1111/bju.14127. Role: primary methodologist.

Klaassen Z, Goldberg H, Chandrasekar T, Hamilton RJ, Fleshner NE, Williams SB, Wallis CJD, Kulkarni GS. Changing trends for suicidal death in patients with bladder cancer: A 40+ year population-level analysis. Clin Genitourin Cancer 2018; 16(3):206-212e1. doi:10.1016/j.clgc.2017.12.016. Role: co-author.

Wallis CJD, Morton G, Herschorn S, Kodama RT, Kulkarni GS, Shayegan B, Buckley R, Grabowski A, Danjoux C, Narod SA, Nam RK. The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation. Br J Cancer 2018; 118(10): 1399-1405. doi:10.1038/s41416-018-0071-4. Role: primary author and primary methodologist.

Wallis CJD*, Klaassen Z*, Bhindi B, Goldberg H, Chandrasekar T, Farrell AM, Boorjian SA, Kulkarni GS, Karnes RJ, Satkunasivam R. Comparison of abiraterone acetate and docetaxel with androgen deprivation therapy in high risk and metastatic hormone-naïve prostate cancer: a systematic review and network meta-analysis. Eur Urol 2018; 73(6): 834-844. doi: 10.1016/j.eururo.2017.10.002 * = authors contributed equally. Role: co-primary author and primary methodologist.

Nam RK, Benatar T, Amemiya Y, Wallis CJD, Romero J, Tsagaris M, Sherman C, Sugar L, Seth A. MicroRNA-652 induces NED in LNCAP and EMT in PC3 prostate cancer cells. Oncotarget 2018; 9(27):19159-19176. doi:10.18632/oncotarget.24937. Role: primary methodologist.

Wallis CJD, Satkunasivam R, Herschorn S, Law C, Seth A, Kodama RT, Kulkarni GS, Nam RK. Association between primary local treatment and non-prostate cancer mortality in men with non-metastatic prostate cancer. Urology 2018; 114:147-154. doi:10.1016/j.urology.2017.12.013. Role: primary author and primary methodologist.

Wallis CJD, Satkunasivam R, Saskin R, Bansal S, Emmenegger U, Nam RK. Population-based analysis of treatment toxicity among men with castrate-resistant prostate cancer. Urology 2018; 113:138-145. doi:10.1016/j.urology.2017.08.067. Role: primary author and primary methodologist.

Klaassen Z, Arora K, Goldberg H, Chandrasekar T, Wallis CJD, Sayyid RK, Fleshner NE, Kutikov A, Finelli A, Violette PD, Kulkarni GS. Extended venous thromboembolism prophylaxis after radical cystectomy: Rationale for standardized care. J Urol 2018; 199(4):906-914. doi:10.1016/j.juro.2017.08.130. Role: co-author.

Wallis CJD*, Cheung DC*, Klotz L, Chalasani V, Leao R, Garisto J, Morton G, Nam RK, Tannock I, Satkunasivam R. Personal PSA screening and treatment choices for localized prostate cancer among expert surgeons. Can Urol Assoc J 2018; 12(2):59-63. http://dx.doi.org/10.5489/cuaj.4736. * = authors contributed equally. Role: co-primary author.

Wallis CJD, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D, Murphy D, Nguyen P, Resnick M, Nam RK. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review. Eur Urol2018; 73(1):11-20. doi: 10.1016/j.eururo.2017.05.055. Role: primary author.

Garbens A, Goldenberg M, Wallis CJD, Tricco AC, Grantcharov TP. The cost of intraoperative adverse events in abdominal surgery: a systematic review and meta-analysis. Am J Surg 2018; 215(1):163-170. doi: 10.1016/j.amjsurg.2017.06.025. Role: co-author.

Wallis CJD, Peltz S, Byrne J, Kroft J, Karanicolas P, Nam RK, Hallet J, Satkunasivam R. Role of Minimally-Invasive Surgery in Peripheral Nerve Injury during Abdominal-Pelvic Surgery – Analysis of the National Surgical Quality Improvement Program Database. Am Surg 2017; 83(11):1214-1219. Role: primary author and primary methodologist.

Wallis CJD, Ravi B, Coburn N, Ellison L, Saskin R, Nam RK, Detsky AS, Satkunasivam R. Comparison of outcomes among patients treated by male and female surgeons. The BMJ 2017;359:j4366. doi:10.1136/bmj.j4366. Role: primary author and primary methodologist.

Wallis CJD, Juvet T, Lee Y, Matta R, Satkunasivam R, Herschorn S, Kodama RT, Kulkarni GS, Geerts W, McLeod A, Narod SA, Nam RK. Association between use of antithrombotic medications and hematuria-related complications. JAMA 2017;318(13):1260-1271. doi: 10.1001/jama.2017.13890. Role: primary author and primary methodologist.

Garbens A, Wallis CJD, Bjarnason G, Kulkarni GS, Nathens AB, Nam RK, Satkunasivam R. Platelet to white blood cell ratio predicts 30-days post-operative infection complications in patients undergoing radical nephrectomy for renal malignancy. Can Urol Assoc J 2017; 11(11):E414-420. http://dx.doi.org/10.5489/cuaj.4478. Role: primary methodologist.

Goldenberg M, Nabhani J, Wallis CJD, Chopra S, Schucman A, Djaladat H, Daneshmand S, Desai MM, Aron M, Gill IS, Satkunasivam R. Feasibility of Expert and Crowd Sourced Review of Intraoperative Video for Quality Improvement of Intra-Corporeal Urinary Diversion During Robotic Radical Cystectomy. Can Urol Assoc J 2017; 11(10):331-336. http://dx.doi.org/10.5489/cuaj.4442. Role: co-author.

Wallis CJD, Saskin R, Narod SA, Law C, Kulkarni GS, Seth A, Nam RK. Estimating the effect of immortal-time bias in urologic research. BJU Int 2017; 120(4):584-590. doi:10.1111/bju.13918. Role: primary author and primary methodologist.

Bhindi B*, Wallis CJD*, Nayan M, Farrell AM, Trost LW, Hamilton RJ, Kulkarni GS, Finelli A, Fleshner NE, Boorjian SA, Karnes RJ. The association between vasectomy and prostate cancer: a systematic review and meta-analysis. JAMA Intern Med2017;177(9):1273-1286. doi:10.1001/jamainternmed.2017.2791. * = authors contributed equally. Role: co-primary author and primary methodologist.

Wallis CJD, Khana S, Hajiha M, Nam RK, Satkunasivam R. Radical cystectomy in patients with disseminated disease: an assessment of peri-operative outcomes using the National Surgical Quality Improvement Program database. Can Urol Assoc J 2017; 11(8):244-8. doi: http://dx.doi.org/10.5489/cuaj.4208. Role: primary author and primary methodologist.

Wallis CJD, Morton G, Jerath A, Satkunasivam R, Szumacher E, Naimark D, Nam RK. Adjuvant versus salvage radiotherapy for patients with adverse prognostic findings following radical prostatectomy: a decision analysis. Med Decis Making Policy & Practice 2017 (e-published 19 May). doi: 10.1177/2381468317709476. Role: primary author.

Wallis CJD, Haider M, Nam RK. Role of mpMRI of the prostate in screening for prostate cancer. Transl Androl Urol 2017; 6(3):464-471. doi: 10.21037/tau.2017.04.31. Role: primary author.

Wallis CJD*, Garbens A*, Chopra S, Gill IS, Satkunasivam R. Robotic partial nephrectomy: expanding utilization, advancing innovation. J Endourol 2017; 31(4):348-354. doi:10.1089/end.2016.0639. * = authors contributed equally. Role: co-primary author.

Wang LI, Wallis CJD, Sathianathen N, Lawrentschuk N, Murphy D, Nam RK, Moon D. ‘ProtecTion’ from overtreatment – does a randomised trial finally answer the key question in localised prostate cancer? BJU Int 2017; 119(4):513-514.doi:10.1111/bju.13734. Role: co-author.

Satkunasivam R, Wallis CJD, Byrne J, Hoffman A, Cheung D, Nathens AB, Nam RK. Peri-operative outcomes following radical prostatectomy for patients with disseminated cancer – an analysis of the National Surgical Quality Improvement Program Database. Can Urol Assoc J 2016;10(11-12):423-429. doi:10.5489/cuaj.3939. Role: primary methodologist.

Wallis CJD*, Cheung DC*, Garbens A, Kroft J, Carr L, Nathens AB, Nam RK, Liu G, Gien L, Satkunasivam R. Occurrence of and Risk Factors for Urological Intervention During Benign Hysterectomy – Analysis of the National Surgical Quality Improvement Program Database. Urology 2016; 97:66-72. 

doi: http://dx.doi.org/10.1016/j.urology.2016.06.037 * = authors contributed equally. Role: co-primary author and primary methodologist.

Wallis CJD, Mahar AL, Satkunasivam R, Herschorn S, Kodama RT, Lee Y, Kulkarni GS, Narod SA, Nam RK. Cardiovascular and skeletal-related events in older men treated for localised prostate cancer: the role of surgery, radiotherapy and androgen-deprivation therapy. Urology 2016; 97:145-152. http://dx.doi.org/10.1016/j.urology.2016.08.002. Role: primary author.

Wallis CJD, Mahar A, Cheung P, Herschorn S, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Hospitalizations to manage complications of modern prostate cancer treatment in older men. Urology 2016; 96:142-147. doi: http://dx.doi.org/10.1016/j.urology.2016.05.054. Role: primary author.

Wallis CJD, Downes MR, Bjarnason G, Satkunasivam R. Isolated Brain Metastasis from a Small Renal Mass. BMJ Case Rep 2016; E-published. doi:10.1136/bcr-2016-216081. Role: primary author.

Satkunasivam R, Wallis CJD, Nam RK, Desai M, Gill IS. Contemporary Evidence for Robotic Radical Cystectomy. Nat Rev Urol 2016; 13:533-539. doi:10.1038/nrurol.2016.139. Role: co-author.

Wallis CJD, Bjarnason G, Byrne J, Cheung D, Hoffman A, Nathens AB, Nam RK, Satkunasivam R. Morbidity and mortality of radical nephrectomy for patients with disseminated cancer – an analysis of the National Surgical Quality Improvement Program Database. Urology 2016; 95:95-102. http://dx.doi.org/10.1016/j.urology.2016.04.055. Role: primary author and primary methodologist.

Wallis CJD, Lundeen C, Golda L, Brotherhood H, Pommerville P, Carr L. Anticholinergics for overactive bladder: temporal trends in prescription and treatment persistence. Can Urol Assoc J 2016; 10(7-8):277-280. http:dx.doi.org/10.5489/cuaj3526. Role: primary author and primary methodologist.

Nam RK, Wallis CJD, Stojcic-Bendavid, J, Milot L, Sherman C, Sugar L, Haider MA. A Pilot Study of the Magnetic Resonance Imaging for Prostate Cancer. J Urol 2016; 196(2):361-365. doi:10.1016/j.juro.2016.01.114. Role: co-author.

Wallis CJD, Lo K, Lee Y, Krakowsky Y, Garbens A, Satkunasivam R, Herschorn S, Kodama RT, Cheung P, Narod SA, Nam RK. Survival and cardiovascular events among men treated with testosterone replacement therapy: an intent-to-treat observational cohort study. Lancet Diabetes Endocrinol 2016; 4(6):498-506. http://dx.doi.org/10.1016/S2213-8587(16)00112-1. Role: primary author and primary methodologist.

Nam RK, Benatar T, Wallis CJD, Amemiya Y, Yang W, Garbens A, Naeim M, Sherman C, Sugar L, Seth A. MiR-301a regulates e-cadherin expression and is predictive of prostate cancer recurrence. The Prostate 2016; 76:869-884. doi:10.1002/pros.23177. Role: primary methodologist.

Wallis CJD, Mahar AL, Choo R, Herschorn S, Kodama RT, Shah PS, Danjoux C, Narod SA, Nam RK. Secondary malignancies following radiotherapy for prostate cancer: a systematic review and meta-analysis. The BMJ 2016; 352:i851. doi:10.1136/bmj.i851. Role: primary author and primary methodologist.

Almatar A, Wallis CJD, Herschorn S, Saskin R, Kulkarni GS, Kodama RT, Nam RK. Effect of Radical Prostatectomy Surgeon Volume on Complication Rates from a Large Population-Based Cohort. Can Urol Assoc J 2016; 10(1-2):45-9. doi:10.5489/cuaj.3214. Role: co-author.

Wallis CJD, Saskin R, Choo R, Herschorn S, Kodama RT, Satkunasivam R, Shah PS, Danjoux C, Nam RK. Surgery versus radiotherapy for prostate cancer: a systematic review and meta-analysis. Eur Urol 2016; 70(1):21-30. doi:10.1016/j.eururo.2015.11.010. Role: primary author and primary methodologist.

Wallis CJD, Mahar AL, Cheung P, Herschorn S, Klotz LH, Al-Matar A, Kulkarni GS, Lee Y, Kodama RT, Narod SA, Nam RK. Examination of New Rates of Interventions to Manage Complications of Modern Prostate Cancer Treatment in Older Men. Eur Urol 2016; 69(5):933-41. doi:10.1016/j.eururo.2015.10.043. Role: primary author.

Wallis CJD*, Gordanpour A*, Nam RK, Stojcic Bendavid J, Sugar L, Seth A. MiR-182 is associated with growth, migration and invasion in prostate cancer via suppression of FOXO1. J Cancer 2015; 6(12):1295-1305. doi:10.7150/jca.13176. * = authors contributed equally. Role: co-primary author and primary methodologist.

Nam RK, Amemiya Y, Benatar T, Wallis CJD, Stojcic-Bendavid J, Bacopulos S, Sherman C, Sugar L, Naeim M, Yang W, Zhang A, Klotz LH, Narod SA, Seth A. Identification and Validation of a Five MicroRNA Signature Predictive of Prostate Cancer Recurrence and Metastasis: a cohort study. J Cancer 2015; 6(11):1160-1171. doi:10.7150/jca.13397. Role: co-author.

Wallis CJD, Nam RK. Prostate Cancer Genetics: A review. Electronic Journal of the International Federation of Clinical Chemistry 2015: 26(2):79-91. PMID: 27683484. Role: primary author.

Wallis CJD, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, Kulkarni GD, Lee Y, Kodama RT, Narod SA, Nam RK. Complications Following Surgery with or without Radiotherapy or Radiotherapy Alone for Prostate Cancer. Br J Cancer 2015; 112:977-982. doi:10.1038/bjc.2015.54. Role: primary author.

Wallis CJD, Herschorn S, Saskin R, Su J, Klotz LH, Chang M, Kulkarni GD, Lee Y, Kodama RT, Narod SA, Nam RK. Complications Following Radical Prostatectomy or Radiotherapy for Prostate Cancer: Results of a Population-based, Propensity-score Matched Analysis. Urology 2015; 85(3):621-628. 

doi:10.1016/j.urology.2014.11.037. Role: primary author.

Wallis CJD, Herschorn S, Liu Y, Carr LK, Kodama RT, Klotz LH, Saskin R, Nam RK. Practice patterns of post-radical prostatectomy incontinence surgery. Can Urol Assoc J 2014; 8(9-10):e670-674. doi:10.5489/cuaj.1959. Role: primary author.

Akbari MR, Wallis CJD, Toi A, Trachtenberg J, Sun P, Narod SA, Nam RK. The Impact of a BRCA2 Mutation on Mortality from Screen-Detected Prostate Cancer. Br J Cancer 2014; 111:1238-1240. doi:10.1038/bjc.2014.428. Role: co-author.

Wallis CJD, Nelson HL, Pommerville PJ. Testosterone deficiency syndrome and cardiovascular health: An assessment of beliefs, knowledge, and practice patterns of general practitioners and cardiologists in Victoria BC. Can Urol Assoc J 2014; 8(1-2):30-33. doi:10.5489/cuaj.1448. Role: primary author.

Wallis CJD, English JC, Goldenberg SL. The role of resection of a solitary pulmonary metastasis from prostate cancer: A case report and literature review. Can Urol Assoc J 2011; 5(6):E104-E108. doi:10.5489/cuaj.10136. Role: primary author.

Nelson HL, Wallis CJD, Pommerville PJ. Isolated Tuberculous epididymitis: A rare complication after intravesical Bacillus Calmette-Guerin therapy. Current Urology 2011; 5(2):106-108. Role: primary author.

El-Zammar D, Yan M, Huang C, Fang D, Petigara F, Bornn L, Ngai T, Brkanovic S, Khangura J, Alexander N, Hendry S, Lubin J, Wallis C, Ford J, Kapoor V. Assessment and management of anemia in a population of children living in the Indian Himalayas: A student-led initiative. University of British Columbia Medical Journal 2011; 2(2):12-18. Role: co-author.

Wallis CJD, Hoag NA, Pommerville PJ, Huk ME. Recurrent idiopathic high-flow priapism treated with selective arterial embolization after repeated initial treatments for low-flow priapism. Can Urol Assoc J 2009; 3(1):60-63. Role: primary author.

bia Medical Journal 2011; 2(2):12-18. Role: co-author.

Wallis CJD, Hoag NA, Pommerville PJ, Huk ME. Recurrent idiopathic high-flow priapism treated with selective arterial embolization after repeated initial treatments for low-flow priapism. Can Urol Assoc J 2009; 3(1):60-63. Role: primary author.

Hospital-, Anesthesiologist-, Surgeon-, and Patient-Level Variations in Neuraxial Anesthesia Use for Lower Limb Revascularization Surgery: A Population-Based Cross-Sectional Study.

Roberts DJ, Mor R, Rosen MN, Talarico R, Lalu MM, Jerath A, Wijeysundera DN, McIsaac DI.Anesth Analg. 2022 Oct 11. doi: 10.1213/ANE.0000000000006232

Association Between Surgeon and Anesthesiologist Sex Discordance and Postoperative Outcomes: A Population-based Cohort Study. Wallis CJD, Jerath A, Kaneshwaran K, Hallet J, Coburn N, Wright FC, Conn LG, Bischof D, Covelli A, Klaassen Z, Zlotta AR, Kulkarni GS, Luckenbaugh AN, Armstrong K, Lim K, Bass B, Detsky AS, Satkunasivam R.Ann Surg. 2022 Jul 1;276(1):81-87. doi: 10.1097/SLA.0000000000005495

Azizi PM, Wijeysundera DN, Wijeysundera HC, Austin PC, Jerath A, Han L, Koh M, Kayssi A, Ko DT. Troponin testing after noncardiac surgery: a population-based historical cohort study on variation and factors associated with testing in Ontario. Can J Anesth. May 2022;69(5):572-81

Wijeysundera DN, Duncan D, Garijo JM, Jerath A, Meineri M, Parotto M, Wasowicz M, McCluskey SA; AMIGO-1 Study Investigators. A randomized controlled feasibility trial of a clinical protocol to manage hypotension during major non-cardiac surgery. Anaesthesia Mar 2022; https://doi.org/10.1111/anae.15715

Wallis CJD, Jerath A, Satkunasivam R. Authors reply to Association of surgeon-patient sex concordance with postoperative outcomes. JAMA Surgery Mar 2022; 157(7): doi:10.1001/jamasurg.2022.0297

Wallis CJD, Jerath A, Kaneshwaran K, Hallet J, Coburn N, Wright F, Gotlib Conn L, Bischoff D, Covelli A, Klassen Z, Zlotta A, Kulkarni G, Luckenbaugh AN, Armstrong K, Lim K, Bass B, Detsky AS, Satkunasivam R. Association between surgeon and anesthesiologist sex disconcordance and postoperative outcomes: a population-based cohort study. Ann Surg. 2022 Jul 1;276(1):81-87. doi: 10.1097/SLA.0000000000005495

Cuninghame S, Gorsky K, Francoeur C, Withington D, Burry L, Jerath A, Slessarev M. Effects of sedation with inhaled anaesthetics on cognitive and psychiatric outcomes in critically ill adults: a systematic review protocol. BMJ Open 2022;12:e052893.

Wallis CJD, Jerath A, Coburn N, Klassen Z, Luckenbaugh AN, Magee DE, Hird AE, Armstrong K, Ravi B, Esnaola NF, Guzman JCA, Bass B, Detsky AS, Satkunasivam R. Association of surgeon-patient sex concordance with postoperative outcomes. JAMA Surgery Jan 2022;157(2):146-56.

Gorsky K, Cuningham S, Chen J, Jayaraj K, Withington D, Francoeur C, Slessarev M, Jerath A. Use of volatile anesthetic agents in pediatric and adult ICU patients for status asthmaticus, status epilepticus and difficult sedation scenarios: A protocol for a systematic review. BMJ Open 2021; 11: e051745. 

Hamad, DA; Mandell, SP; Stewart, RM; Patel, B; Guttman, MP; Williams, P; Thomas, A; Jerath, A; Bulger, EM; Nathens, AB. Error in trauma care: lessons from an anonymized, national multicentre mortality reporting system. Journal of Trauma and Acute Care Surgery Mar 2022: 92(3):473-80. 

    McIsaac DI, Talarico R, Jerath A, Wijeysundera DN. Days alive and at home after hip fracture: a cross-sectional validation of a patient-centred outcome measure using routinely collected data

BMJ Quality & Safety Published Online First: 30 July 2021. doi: 10.1136/bmjqs-2021-013150. 

Azizi PM, Wijeysundera DN, wijeysundera HC, Austin PC, Jerath A, Han L, Koh M, Kayssi A, Ko DT. High hospital-specific postoperative troponin testing intensity was associated with improved outcomes after major vascular surgery.

Circulation Nov 2021; 144 (Suppl 1): A8909

Azizi PM, Wijeysundera DN, wijeysundera HC, Austin PC, Jerath A, Han L, Koh M, Kayssi A, Ko DT. Troponin testing after noncardiac surgery in Ontario: An observational study. CJC Open 2021 Jul; 3(7):904-12

Hallet, J, Jerath A, Sutradhar R. Looking over the drape – anesthesiologists’ volume and surgical outcomes – Reply. JAMA Surgery. Jan 2022;157(1):79. 

Azizi P, Wijeysundera DN, Austin PC, Wijeysundera H, Lu H, Koh M, Jerath A, Ko DT. Troponin testing after non-cardiac surgery: variation and factors associated with testing. Can J Anesth May 2021: In Press.

Skelhorne-Gross G, Nenshi R, Jerath A, Gomez D. Emergency general surgery in Ontario: inter-hospital variability in structures, processes, and models of care in a cross-sectional survey. CMAJ Open 2021 Oct; 9(4): E1026-33. 

Choi S, Jerath A, Jones P, Avramescu S, Djaiani G, Syed S, Saha T, Kaustov L, Kiss A, D’Aragon F, Hedin P, Rajamohan R, Couture EJ, Singh A, Mapplebeck CS, Wong S, Orser BA. Cognitive outcomes after dexmedetomidine sedation in cardiac surgery: CODEX randomized controlled trial. BMJ Open. 2021 Apr;13(11):e046851. doi.10.1136/bmjopen-2020-046851. 

Hallet J, Jerath A, Turgeon AF, McIsaac D, Eskander D, Zuckerman J, Zuk V, Sohail S, Dharma C, Coburn N, Sutradhar R. The association between anesthesia provider-volume and short-term outcomes in complex gastrointestinal cancer surgery: a population-based analysis. JAMA Surgery May 202;156(5):479-87. 

Azizi PM, Han L, Koh M, Jerath A, Wijeysundera HC, Wijeysundera DN, Austin PC, Ko DT. Substantial Hospital variation in troponin testing after non-cardiac surgery. Circulation 2020 Nov 17th; 142(Suppl 3): A14288. 

Jerath A, Wijeysundera DN. The authors respond to “Delayed discharge and frailty, delirium and functional decline”. CMAJ 2021 Feb;193(6):E222. Principal Author

Jerath A, Wong K, Wasowicz M, Fowler T, Steel A, Grewal D, Huszti E, Parotto M, Zhang H, Wilcox ME, McDonald B, Overgaard C, Rao V, Ferguson ND. Use of inhaled volatile anesthetics for longer-term critical care sedation: A pilot randomized controlled trial. Crit Care Expl Nov 19th 2020; 2 (11); pe0281. Principal Author

Wong J, George R, Hanley CM, Saliba C, Yee DA, Jerath A. Tranexamic acid: Current use in trauma, obstetrics and major orthopedic surgery. Can J Anesth 2021 Jun;68(6):894-917. Invited Continue Professional Development module. 

Looby N, Vasiljevic T, Reyes-Garces N, Roszkowska A, Bojko B, Wasowicz M, Jerath A, Pawliszyn J. Therapeutic drug monitoring of tranexamic acid in plasma and urine of renally impaired patients using solid phase microextraction. Talanta 2021 Apr;225:121945https://doi.org/10.1016/j.talanta.2020.121945. 

Hanley CM, Callum J, Jerath A. Tranexamic acid and trauma coagulopathy: where are we now?. Brit J Anaesth. 2021

Jan;126(1):12-17. doi: 10.1016/j.bja.2020.09.014. 

Verret M, Lauzier F, Zarychanski R, Perron C, Savard X, Pinard AM, Leblanc G, Cossi MJ, Neveu X, Turgeon AF (Jerath A);Canadian Perioperative Anesthesia Clinical Trials (PACT) Group. Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain: A Systematic Review and Meta-analysis. Anesthesiology 2020 Aug; 133(2): 265-79. 

Riedel B, Li MHG, Lee CHA, Ismail H, Cuthbertson BH, Wijeysundera DN, Ho KM (Jerath A); METS study investigators. A simplified (modified) Duke Activity Status Index (M-DASI) to characterise functional capacity: a secondary analysis of the Measurement of Exercise Tolerance before Surgery (METS) study. BJA 2020 Jul 17:S0007-0912(20)30462-1. doi: 10.1016/j.bja.2020.06.01. 

Jerath A, Sutherland J, Ko DT, Wijeysundera HC, Fremes SE, Karanicolas P, McCormack D, Wijeysundera DN. Delayed discharge following major surgical procedures. Can Med Ass J. 2020 Nov; 192(46):E1440-52.

Jerath A, Ferguson ND, Cuthbertson B. Inhalational volatile-based sedation for COVID-19 pneumonia and ARDS. Inten Care Med 2020 Aug 46 (8);1563-66, doi: 10.1007/s00134-020-06154-8. 

Azizi PM, Koh M, Austin PC, Han L, Jerath A, Wijeysundera DN, Wijeysundera HC, Ko DT. Substantial Hospital variation in troponin testing after non-cardiac surgery. Circ Cardiovasc Qual Outcomes 2020 May; 14 (Suppl 1): A324

Wijeysundera DN, Beattie WS, Hillis GS, (Jerath A), METS study investigators. Integration of the Duke activity status index into preoperative risk evaluation: a multicenter prospective cohort study. Brit J Anaesth 2020 Mar;124(3):261-70

Jerath A, Austin PC, McCormack D, Wijeysundera DN. Impact of postoperative intensive care unit utilization on postoperative outcomes in adults undergoing major elective noncardiac surgery. J Clinical Anesthesia 2020 Jan; 14; 62: 

Jerath A, Austin PC, Ko DT, Wijeysundera HC, Fremes S, McComack D, Wijeysundera DN. Socioeconomic status and days alive and out of hospital after major noncardiac surgery: A population based cohort study. Anesthesiology 2020 Apr; 132: 713-22.

Taam J, Pang KS, Yang Q, Karanicolas P, Choi S, Wasowicz M, Jerath A. Current evidence and future directions of tranexamic acid use, efficacy and dosing for major surgical procedures. J Cardiothorac Vasc Anes. 2020 Mar; 34(3): 782-90.

Ackland GJ, Abbott TEF, Minto G, (Jerath A), METS and POM-HR study investigators. Correction: Heart rate recovery and morbidity after noncardiac surgery: planned secondary analysis of two prospective, multicenter, blinded observational studies. PLOS One 2019 Dec; 14(12): e0226379. 

Edwards MR, Forbes G, MacDonald N, Berdunov, Mihaylova B (Jerath A), OPTIMISE II Investigators. Optimisation of perioperative cardiovascular management to improve surgical outcome II (OPTIMISE II) trial: study protocol for a multicenter international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open 2019;9:e023455. 

Ackland GJ, Abbott TEF, Minto G, (Jerath A), METS and POM-HR study investigators. Heart rate recovery and morbidity after noncardiac surgery: planned secondary analysis of two prospective, multicenter, blinded observational studies. PLOS One 2019 Aug; 14(8): e0221277. 

Bartoszko J, Thorpe KE, Laupacis A, Jerath A, Wijeysundera DN. Association of preoperative anemia with cardiopulmonary exercise capacity and postoperative outcomes in noncardiac surgery: a substudy of the Measurement of Exercise Tolerance before Surgery (METS) Study. Brit. J. Anesth. 2019 June; doi: 10.1016/j.bja.2019.04.058. 

Jerath A, Austin P, Wijeysundera DN. Days alive and out of hospital: Validation of a patient-centered outcome for perioperative Medicine. Anesthesiology 2019 Jul; 131(1):84-93. 

Jerath A, Yang Q, Wasowicz M, Pang KS. Tranexamic acid pharmacokinetics. To the Editor. Anesth Analg 2019 Jun; 128(6): e125-e126. doi: 10.1213/ANE.0000000000004144. 

Ladowski S, Jerath A. Core topic in cardiothoracic critical care. Anesth Analg 2019 Mar; 128(3): e45 DOI: 10.1213/ANE.0000000000003993. 

Edwards MR, Forbes G, MacDonald N, Berdunov V, Wijeysundera D, Pearse RM, Jerath A, OPTIMISE II Investigators. Optimisation of perioperative cardiovascular management to improve surgical outcome II (OPTIMISE II) trial: study protocol for a multicenter international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open Jan 2019; 9(1): e023455. 

Yang Q, Jerath A, Wasowicz M, Pang KS. Factors that influence tranexamic acid overdose in cardiac surgical patients with chronic renal dysfunction. Drug Metab Pharm 2019 Jan; 34(1): S68. 

Shulman MA, Cuthbertson BH, Wijeysundera DN, Pearse RM, Jerath A, METS study investigators. Using the 6-minute walk test to predict disability-free survival after major surgery. Brit J Anesth. 2019 Jan;122(1): 111-9. 

Jerath A, Laupacis A, Austin PC, Wunsch H, Wijeysundera DN. Intensive care utilization following major noncardiac surgical procedures in Ontario, Canada: a population-based study. Intensive Care Med 2018 Sep; 44(9): 1427-35. 

Wijeysundera DN, Pearse RM, Myles PS, Jerath A, Cuthbertson BH, METS study investigators.  Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study. The Lancet 2018 Jun; 391(10140):2631-40. 

Wasowicz M, Jerath A, Luksun W, Sharma V, Mitsakakis N, Meineri M, Katznelson R, Yau T, Rao V, Beattie WS. Comparison of propofol-based versus volatile-based anesthesia and postoperative sedation in cardiac surgical patients: a prospective, randomized study. Anaesthesiol Intensive Ther. 2018 Jun; 50(3): 200-9. 

Jerath A, Wijeysundera DN. The hidden consequences of the changing cardiac surgical population. Can J Anesth. 2018 Sep; 65(9): 973-8.

Jerath A, Parotto M, Wasowicz M, Ferguson ND. Opportunity Knocks? The expansion of volatile agent use in new clinical settings. J Cardiothorac Vasc Anesth. 2018 Aug; 32(4):1946-54.

Jerath A, Yang Q, Pang SK, Looby N, Reyes-Garces N, Vasilijevic T, Bojko B, Pawliszyn J, Wijeysundera D, Beattie WS, Yau T, Wąsowicz M.  Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: A new dosing regimen. Anesth Analg. 2018 Dec;127(6):1323-133 

Arora R, Sobey A, Jerath A, Kushner B, Coullard P, Ferland A, Grocott H, McDonald B, Skrobik Y et al. Incidence of delirium after cardiac surgery: protocol for the DELIRIUM-CS Canada cross-sectional cohort study. Can Med Ass J. Open 2017; 5(3): E565-9. 

Wallis CJD, Morton G, Jerath A, Satkunasivam R, Szumacher E, Kodama R, Naimark D, Kulkarni G, Nam R. Adjuvant versus salvage radiotherapy for patients with adverse pathological findings radical prostatectomy: a decision analysis. Med Dec Making. 2017 May; doi 2381468317709476. 

Yang Q, Kluger M, Gorynski K, Pawliszyn J, Bojko B, Yu AM, Noh K, Selzner M, Jerath A, McCluskey S, Pang KS, Wasowicz M.  Comparing Early Liver Graft Function From Heart Beating and Living-Donors. A Pilot Study Aiming to Identify New Biomarkers of Injury. Biopharm Drug Dispos. 2017 Jul; 38(5):326-39. 

Jerath A, Wasowicz M. In reply: Anesthesia scavenging in critical care areas: beware of possible hazards and questionable efficacy, Can J Anesth 2017 Jan; 64(1):98-9. 

Jerath A, Panckhurst J, Parotto M, Lightfoot N, Ferguson ND, Steel A, Beattie WS. The safety and efficacy of volatile anesthetic agents compared to standard intravenous benzodiazepine/propofol sedation in ventilated critical care patients: A meta-analysis and systematic review of prospective trials. Anesth Analg. 2017 Apr;124(4):1190-9. 

  Jerath A, Parotto M, Wasowicz M, Ferguson ND. Volatile Anesthetics: Is A New Player Emerging in Critical Care Sedation? Am J Respir Crit Care Med. 2016 Jun;193(11):1202-12. 

  Wijeysundera DN, Pearse RM, Myles PS, (Jerath A), Cuthbertson BH, METS study investigators.  Measurement of exercise tolerance before surgery (METS) study: a protocol for an international multicenter prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery. BMJ Open 2016;9(e010359);1-10. 

  Deschamps A, Hall R, Grocott H, Mazer CD, Choi PT, Turgeon AF, de Medicis E, Bussières JS, Hudson C, Syed S, Seal D, Herd S, Lambert J, Denault A, Deschamps A, Mutch A, Turgeon A, Denault A, Todd A, Jerath A et al. Canadian Perioperative Anesthesia Clinical Trials Group. Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology. 2016 Apr;124(4):826-36. 

  Puentes W, Jerath A, Djaiani G, Cabrerizo Sanchez R, Wasowicz M. Early versus late tracheostomy in cardiovascular intensive care patients. Anaesthesiol Intensive Ther. 2016 Mar;48(2):89-94. 

  Del Sorbo L, Jerath A, Dres M, Parotto M. Noninvasive ventilation in immunocompromised patients with acute hypoxemic respiratory failure. J Thorac Dis. 2016 Mar;8(3):E208-16. 

  Wong K, Wasowicz M, Grewal D, Fowler T, Ng M, Ferguson ND, Steel A, Jerath A. Efficacy of a simple scavenging system for long-term critical care sedation using volatile agent-based anesthesia. Can J Anaesth. 2015 Dec;63(5):630-2. 

  Jerath A, Ferguson ND, Steel A, Wijeysundera D, Macdonald J, Wasowicz M. The use of volatile anesthetic agents for long-term critical care sedation (VALTS): study protocol for a pilot randomized controlled trial. Trials. 2015 Dec;16(1):560. 

  Yang Qi, Jerath A, Bies RR, Wasowicz M, Pang KS. Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment. Biopharm Drug Dispos. 2015 Jul;36(5):294-307. 

  Jerath A, Beattie SW, Chandy T, Karski J, Djaiani G, Rao V, Yau T, Wasowicz M. Perioperative Anesthesia Clinical Trials Group. Volatile-based short term sedation in cardiac surgical patients:  A prospective randomized controlled trial. Crit Care Med. 2015 May;43(5):1062-9. 

  Ng WC, Jerath A, Wasowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015 Apr;47(4):339-350. 

Wasowicz M, Jerath A. The introduction of a lightweight mini vaporizer and malignant hyperthermia: author reply. Can J Anaesth. 2015 Mar;62(3):320. 

  Wąsowicz M, Jerath A. Expanding the use of volatile anesthetic agents beyond the operating room. Can J Anaesth. 2014 Oct;61(10):905-8. 

  Gorynski K, Bojko B, Kluger M, Jerath A, Wąsowicz M, Pawliszyn J. Development of SPME method for concomitant sample preparation of rocuronium bromide and tranexamic acid in plasma. J Pharm Biomed Anal. 2014 Apr;92:183-92. 

  Sharma V, Katznelson R, Jerath A, Garrido-Olivares L, Carroll J, Rao V, Wasowicz M, Djaiani G. The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients. Anaesthesia. 2014 Feb;69(2):124-30. 

  Vegas A, Meineri M, Jerath A, Corrin M, Silversides C, Tait G. Impact of online transesophageal echocardiographic simulation on learning to navigate the 20 standard views. J Cardiothorac Vasc Anesth. 2013 Jun;27(3):531-5. 

  Pickworth T, Jerath A, DeVine R, Kherani N, Wasowicz M. The scavenging of volatile anesthetic agents in the cardiovascular intensive care unit environment: a technical report. Can J Anaesth. 2013 Jan;60(1):38-43. 

  Sharma V, Fan J, Jerath A, Pang KS, Bojko B, Pawliszyn J, Karski JM, McCluskey S, Wasowicz M. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass. Anaesthesia. 2012 Nov;67(11):1242-50. 

  Jerath A, Roscoe A, Vegas A. Normal upper esophageal transesophageal echocardiography views. Anesth Analg. 2012 Sep;115(3):507-10. 

  Vegas A, Jerath A. Upper esophageal transesophageal echocardiography views pathology. Anesth Analg. 2012 Sep;115(3):511-6.

  Bojko B, Vuckovic D, Mirnaghi F, Cudjoe E, Wasowicz M, Jerath A, Pawliszyn J. Therapeutic monitoring of tranexamic acid concentration: High throughput analysis with solid phase microextraction. Ther Drug Monit. 2012 Feb;34(1):31-7.

  Wasowicz M, Jerath A, Bojko B, Sharma V, Pawliszyn J, McCluskey S. Use of a novel technique of Solid Phase Microextraction to measure concentration of tranexamic acid in patients undergoing cardiac surgery. Can J Anesth. 2012 Jan;59(1):14-20. 

  Bojko B, Vuckovic D, Cudjoe E, Hoque ME, Mirnaghi F, Wąsowicz M, Jerath A, Pawliszyn J. Determination of tranexamic acid concentration by solid phase microextraction and liquid chromatography-tandem mass spectrometry: first step to in vivo analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec;879(32):3781-7. 

  Jerath A, Murphy P, Madonik M, Barth D, Granton J, de Perrott M. Pulmonary endarterectomy in sickle cell haemoglobin C disease. Eur Respir J. 2011 Sep;38(3):735-7.

  Jerath A, Vegas A, Meineri M, Silversides C, Feindel C, Beattie S, Corrin M, Tait G. An interactive online 3D model of the heart to assist in learning standard transesophageal echocardiography views. Can J Anesth. 2011 Jan;58(1):14-21. 

  Jerath A, Jaura A, Karski J, Feindel C, Butany J, Vegas A. Left-sided migration of Sideris button atrial septal occluder device. Eur J Echocardiogr. 2010 Jun;11(5):E21. 

77.   Jerath A, Srinivas C, Brister S, Vegas A. The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin. Anesth Analg. 2010 Feb;110(2):365-9.